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ABSTRACT 
INTRODUCTION:  Attention Deficit/Hyperactivity Disorder (ADHD) is a disorder that 
is prevalent throughout the world.  It is believed that 5% of school aged children suffer 
from ADHD, with some estimates indicating as high as 10% may suffer from the 
disorder.  Primarily, three subtypes of ADHD have been associated with certain 
electroencephalographic (EEG) abnormalities.  The most common treatment for ADHD 
is medication.  However, neurofeedback is considered an efficacious treatment for 
ADHD. It is proposed that neurofeedback training aimed to mitigate inattention and low 
arousal in ADHD will be accompanied by changes in EEG bands' relative power.  
 
DATA COLLECTION:  Patients were 18 children with ADHD. The neurofeedback 
protocol used to train patients has focused attention training mode, which according to 
specifications, represents an EEG desynchronization measure. The neurofeedback 
protocol provides one numeric output for "Focus” and one numeric output for 
“Alertness”. This does not allow for collecting information regarding changes of specific 
EEG bands’ power within 2-45 Hz range.  Therefore, data was collected for EEG bands 
through the use of BioExplorer and BioReview software.  Each subject completed 12 
sessions with a target length of 25 minutes per session.  Additionally, IVA+Plus test and 
ABC behavioral survey measures were administered both pre- and post- neurofeedback. 
 
DATA PROCESSING AND ANALYSIS: Analysis was completed on each of the 25 min 
long twelve sessions using a custom-made MatLab application to determine the relative 
power of each of the EEG bands throughout each session and from the first session to the 
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last session. Additional statistical analysis was performed to determine significant 
changes in relative power within sessions (from minute 1 to minute 25), and between 
sessions (from session 1 to session12) for an individual patient using an ANOVA. 
Additionally, a correlation analysis was performed to determine possible correlations 
between the “Focus” measure and changes in relative power of Theta, Alpha, Low and 
High Beta, Theta/Alpha, Theta/Beta, and Theta/Low Beta and Theta/High Beta ratios. 
Additional measures of patients’ post-neurofeedback outcomes were assessed using an 
audio-visual selective attention test and behavioral evaluation scores and analyzed 
through a paired t-test. 
  
RESULTS:  Through statistical analysis of the data computed in the MatLab application, 
we determined that, as expected, Theta/Low Beta and Theta/Alpha ratios decreased 
significantly from Session 1 to Session 12 and from minute 1 to minute 25 within 
sessions. "Focus" measure also demonstrated a significant gradual increase from session 
1 to session 12 and from minute 1 to minute 25 within sessions. The “Focus” measure of 
the protocol showed high negative correlation with both Theta/Alpha and Theta/Beta 
ratios.  
 
CONCLUSIONS:  The findings will help in elucidation of neural mechanisms of 
neurofeedback aimed to improve focused attention in ADHD.   Also, this analysis differs 
from those prior studies in the consideration of what is transpiring not only from session 
to session, but also within each session. Therefore, improvement can be indicated within 
a shorter number of sessions (i.e. 12) compared to previous protocols that required 30-40 
vii 
 
sessions per subject to indicate statistically significant improvement either in EEG or 
clinical behavioral measures.  Probably more than 12 sessions might contribute to better 
consolidation of results of operant conditioning using neurofeedback and currently, we 
have a study in progress that will compare outcomes of 12 vs. 18 sessions of 
neurofeedback using the same protocol. 
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I. INTRODUCTION 
 
A. ADHD Prevalence and Clinical Significance 
Attention Deficit/Hyperactivity Disorder (ADHD) is a disorder that is prevalent 
throughout the world.  It is believed that 5% of school aged children suffer from ADHD, 
with some estimates indicating as high as 10% may suffer from the disorder (American 
Psychiatric Association, 2000; Faraone et al. 2003). Male children are 3 times as likely as 
female children to be diagnosed and treated for ADHD.  The primary indications of 
ADHD are moderate to extreme inattention, evidenced by the inability to "focus" on 
specific tasks, and the hyperactivity component evidenced through fidgeting, agitation, 
and impulsivity (Biederman 2005; Gevensleben et al. 2009). Of the 5% of children that 
exhibit ADHD symptoms in childhood, 30-50% of those children exhibit symptoms in a 
chronic manner that continues to present into adulthood (Holtmann and Stadler 2006).  
Although, certain diagnostic differences exist between children who outgrow the disease 
compared to children who continue to present in adulthood (Clarke et al. 2010). The 
functional outcomes of ADHD can be detrimental to childhood development and prevent 
the necessary foundation for a successful life.  Common problems associated and 
attributed to ADHD include poor academic performance, lower occupational success, 
increased risk-taking behavior, and diminished social relationships (Holtmann and 
Stadler 2006). The literature also cites that ADHD diagnoses increase the likelihood of 
other psychiatric diagnoses, which could lead to impaired functional adaptations later in 
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life (Gillberg et al. 2004; Gevensleben et al. 2009).  This distinction of an ADHD 
diagnosis accounts for the high prevalence of comorbidities associated with ADHD that 
are common in childhood cases.  For instance, diagnoses of ADHD are commonly 
associated with psychiatric disorders including, but not limited to, conduct disorder, 
oppositional defiant disorder, and learning disorders (Pliszka 1998; Holtmann and Stadler 
2006). 
 
B. Causes of ADHD in Childhood Population 
Despite similar diagnosis amongst a large patient demographic, the underlying 
causes of ADHD are varied, but well documented.  Extensive research (Biederman 2005) 
demonstrates the strongest indicator of ADHD is a genetic/hereditary etiology with 
environmental factors believed to play a key role.  Studies (Faraone et al. 2005) have 
shown that a familial connection with ADHD increases the chances of exhibiting the 
disorder by a factor of 2 to 8.  Since familial studies don't expressly separate genetic and 
environmental factors, twin and adoption studies have been utilized to determine the 
balance of effects believed to cause ADHD.   Based on extensive twin studies (Faraone 
and Mick 2010), it was hypothesized that approximately 76% of the cause of ADHD 
could be attributed to familial factors and genetic.  When correcting for bias due to 
interaction between twins, the estimate was reduced, although still the majority, with 
familial influence accounting for 60% of the diagnoses of ADHD (Cortese 2012; Wood 
et al. 2009).  Additionally, adoption studies (Cortese 2012) have been clear in their 
implications regarding the hereditary nature of ADHD.  In adoption studies, it has been 
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shown that children with a biological connection to ADHD are more likely to exhibit 
hyperactivity than their adoptive counterparts with no biological link to ADHD. 
 
C. EEG Subtype Characteristics of ADHD and Comorbidities 
Attention Deficit/Hyperactivity Disorder has been known to associate with certain 
symptoms for many years.  However, recently interest has been focused on studying the 
EEG patterns of children with ADHD to determine whether certain abnormalities existed 
in the EEG patterns of diagnosed children and how those abnormalities correlate to 
clinical manifestations of ADHD.  As a result of initial studies (Barry, Clarke, and 
Johnstone 2003), it has been determined that compared to gender- and age-matched 
control, children with ADHD express three different manifestations of EEG signals.  In 
general, EEG signals are separated into frequency ranges for characterization purposes.  
The range of frequencies for each group can vary, but from low to high frequencies the 
characterization is Delta, Theta, Alpha, Beta, and Gamma ranges.  One group shows an 
increase in slow wave activity (e.g. Delta) and a decrease in the faster wave (e.g. Alpha 
and Beta) frequencies (Clarke et al. 2001, 2002). This group was initially labeled as 
"maturationally-lagged."  A second group, labeled "hyperaroused", showed increased 
Theta amplitude, with decreased Beta activity (Clarke et al. 1998, 2001, 2002).  
Intuitively, this manifests as an increase in the Theta/Beta ratio, which has been shown to 
be one of the most significant measures changing in ADHD treatment studies (Barry, 
Clarke, and Johnstone 2003).   The third group, also identified tentatively as 
"hyperaroused", exhibited an increase in Beta activity (Clarke et al. 2001).  However, as 
previously noted, ADHD diagnosis commonly presents with comorbidities.  The studies 
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isolating these groups screened exclusively for children only presenting an ADHD 
diagnosis.  Therefore it was not representative of the clinical population.  As a result, an 
additional study has been completed where children were not screened for comorbidities 
prior to inclusion. 
In the most recent study into EEG subtypes relating to ADHD, Clarke et al. 
(2011b) separated the EEG manifestations into five clusters, with two being later 
combined due to similarities to yield a total of four central nervous system (CNS) 
abnormalities.  In this study, the two combined clusters displayed an increase in total 
power and Theta signals with a decrease in Alpha and Beta activity.  This combined 
cluster was designated in a previous study (Barry, Clarke, and Johnstone 2003) as 
"hyperarousal" and represented 35% of patients in this study (Clarke et al. 2011b).   
Another cluster of patients presented with an increase in Delta and Theta activity and a 
decrease in Alpha activity coupled with a decrease in total power (Clarke et al. 2011b).  
This cluster is comparable to the previously labeled group defined as "maturationally-
lagged (Barry, Clarke, and Johnstone 2003)."  The final cluster that was previously noted 
and tentatively labeled as "hyperarousal" (Barry, Clarke, and Johnstone 2003) 
represented 23% of patients in this study (Clarke et al. 2011b).  This group presented 
with increased total power and Beta activity.  Additionally, this cluster displayed some 
decrease in Theta and Alpha activity.  Finally, the last cluster determined in this group of 
patients, representing 17% of patients, did not present in the previous study which 
excluded all comorbidities (Clarke et al. 2011b).  As a result of this newly identified 
group, which displayed increased Alpha activity with decreased Delta and Theta activity 
(Clarke et al. 2011b), no attempt was made to characterize this subtype.   
5 
 
 An extension of the linking of EEG characteristics to the ADHD diagnosis, 
concerns the connection between EEG patterns and clinically relevant subtypes of the 
ADHD diagnosis.  The three DSM-IV subtypes of ADHD investigated by Clarke were 
Inattentive, Hyperactive-Impulsive, and Combined (2011b).  Inattentive and Combined 
subscales showed a correlation with the Theta band, represented by two clusters in one 
EEG characteristic study (Clarke et al. 2011b).  The other measure to display correlation 
specifically with a subtype was the Theta/Beta ratio, which showed a correlation with 
Hyperactive-Impulsive subtype, as well as the Combined subtype with two EEG clusters 
associating with these clinical subtypes (Clarke et al. 2011b). 
As previously noted, a common clinical manifestation of ADHD involves many 
possible comorbid diagnoses.  The increased Theta activity found in ADHD EEG 
characterizations has also been found in some of these diagnoses (e.g. learning 
disabilities, mental retardation, etc.).  Whereas, increased Theta activity was originally 
theorized to be a result of brain dysfunction, the association of increased Theta activity 
with Inattentiveness shows that it is possible that Theta activity is actually an indicator of 
inattention (a symptom present in all these comorbid diagnoses) (Clarke et al. 2011a).  A 
study (Clarke et al. 2011a) of ADHD patients presenting with a comorbid diagnosis of 
autism with a group presenting only with ADHD found several qualitative differences 
between the two groups.  However, the primary diagnosis for each group was ADHD.   
This study found that a second comorbid group presented EEG abnormalities that could 
be considered independent of the ADHD diagnosis.  Based on these findings by Clarke et 
al. (2011a), the inclusion of participants with comorbid disorders in ADHD studies seems 
logical. 
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D. ADHD Treatment Options 
 
1. Pharmacological 
 
Due to the broad, highly present, and potentially severe impact of ADHD, it is of high 
importance to efficaciously and safely treat the symptoms of ADHD.  The most prevalent 
method of treatment for ADHD is the use of medication, whether it be stimulant based 
(i.e. methylphenidate – the most prominent medication) or nonstimulant based (i.e. 
atomoxetine) (The MTA Cooperative Group 1999).  Both varieties of medication have 
been shown to be efficacious for treatment of symptoms; however, 25 - 30% of patients 
experience no response to medication or adverse effects (Greenhill et al. 1999, 2001).  
Additionally, withdrawal of medication results in patients reverting to previous levels of 
symptoms.   Another important consideration regarding disadvantages of 
pharmacological treatment is that parents/guardians generally are hesitant to this 
approach due to side effects commonly associated with medicine (e.g. appetite loss) and 
the stigma associated with long-term medication in children (Taylor et al. 2004; 
Banaschewski et al.2006).  Besides pharmacological treatments, several non-
pharmacological treatments have been considered in the clinical setting, such as dietary 
elimination strategies, with results showing a non-significant impact for the majority of 
ADHD patients (Ferguson 2000). 
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2. Non-Pharmacological 
 
However, one non-pharmacological solution that has yielded positive results is 
neurofeedback (also called EEG biofeedback) training.  The primary rationale for the 
utilization of neurofeedback in the treatment of ADHD stems from studies showing 
abnormal EEG findings in patients with ADHD (Barry, Clarke, and Johnstone 2003).  In 
the majority of patients presenting with ADHD, studies have shown that there is a 
cortical slowing, or hypo-arousal, in some cases during EEG examinations (Monastra 
2005; Holtmann and Stadler 2006).  Therefore, neurofeedback treatments have been 
developed to target the two previously noted EEG abnormalities. It was theorized that 
through reinforcing a specific change in cortical activity through an auditory or visual 
display that the patient could normalize this reinforced activity and develop the ability to 
maintain and control targeted behavior (i.e. hyperactivity or inattention) (Monastra 2005).   
Initially, proof of biofeedback producing significant changes in EEG signals was 
demonstrated in non-human models (Wyrwicka and Sterman 1968).  Later, the first 
documented use of "Sensorimotor Rhythm" (SMR) training in the treatment of ADHD 
was accomplished in humans (Lubar and Shouse 1976).  SMR training targets the brain 
waves in the 12-15 Hz range at the motor cortex, but this research was later expanded to 
include increasing EEG activity at higher frequencies (16-20 Hz or "Beta"), while 
suppressing activity at lower frequencies (4-8 Hz or "Theta").  As a result of these 
studies, clinical responses have been demonstrated in hyperactive children when treated 
with neurofeedback (Lubar and Shouse 1976).  Most recently, several papers (Arns et al. 
2009; Gevensleben et al. 2009; Sherlin et al. 2010a; Van den Bergh 2010) have reported 
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neurofeedback as being an efficacious treatment in subjects with ADHD.  These include 
meta-analysis, randomized clinical trials, and literature reviews supporting clinical 
efficacy associated with the utilization of neurofeedback. Therefore, neurofeedback as a 
treatment for ADHD is widely regarded as having Level 5 (efficacious and specific) 
efficacy as described by the American Psychological Association (Sherlin et al. 2010a).  
However, some clinicians in ADHD treatment area have certain concerns and argue that 
neurofeedback should be considered less efficacious clinically (Lofthouse, Arnold, and 
Hurt 2010).  Nevertheless, the topic of clinical efficacy level of neurofeedback-based 
intervention in ADHD is still far from consensus and encourages more basic EEG 
research and clinical trials (Sherlin et al. 2010b).    
Three general protocols are prevalent in the literature and have been investigated 
and shown efficacy in the treatment of ADHD.  One such protocol is the SMR 
Enhancement/Theta Suppression.  In this protocol, patients receive feedback based on the 
amount of time that the SMR signal is above pretreatment thresholds and the Theta signal 
is below pretreatment thresholds (Rossiter and La Vaque 1995).  A secondary protocol 
utilizes SMR Enhancement combined with "Beta-2" (22-30 Hz) suppression (Fuchs et al. 
2003).  A third protocol, derived from the second protocol, involved the reinforcement of 
Theta suppression with "Beta-1" (13-22 Hz) enhancement (Linden, Habib, and Radojevic 
1996).  One more approach to neurofeedback application in ADHD treatment proposes a 
protocol (so called “Focus/Alertness” training) that uses wide band EEG spectrum 
suppression (Sokhadze 2012) rather that control of individual bands. 
Due to the difficulty in interpretation of the meaning of the Theta-Beta ratios and 
other EEG terminology, terms such as “Focus” and “Alertness” that are defined in a clear 
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way and can be understood through some simple introduction lessons have been 
developed. Sokhadze has described this protocol in detail (Sokhadze 2012).  For instance, 
instead of telling a subject to suppress Theta or increase Beta, the subject is only 
instructed to increase "Focus". "Focus", in actuality, is a desynchronization measure of 
activation of the underlying cortex. This protocol has also been referenced as “InAll”, 
“InhibitAll”, or wide band suppression. Using "Focus" as a measure, the higher the 
quality of visualization of an activity, the larger the resulting "Focus" measure. This is 
extremely valuable for training via visualization. In contrast to "Focus", "Alertness" is 
primarily a numerical representation of the arousal of the central nervous system, 
responsible for creating the underlying pattern of psychophysiological changes associated 
with excitement and the “fight or flight” response. This measure of the underlying 
common pattern of emotional engagement can potentiate a variety of emotions: anxiety, 
anger, interest, and excited happiness. If these experiences are absent, then lower values 
of “Alertness” may reflect a calm or relaxed state. Alertness seems to be a good measure 
of the continuum underneath the inverted U shaped curve relating the quality of 
performance to arousal. Finding the ideal level of “Alertness” for every point in the 
sequence of an activity by recording the EEG during visualization or video replay can be 
very valuable. It is far better training than just trying to adjust the level of Alertness at the 
beginning of the sequence. The "Focus" and "Alertness" measures were trained using the 
"Peak Achievement Trainer" that is commercially available (Cowan and Albers 2008).  
Prior studies have shown positive outcomes using this device (Sokhadze 2012). 
 
 
10 
 
E. Goals and Expectations of this Study 
The goal of this study was to conduct neurofeedback in ADHD subjects using the Peak 
Achievement Trainer (PAT) device with the "Focus/Alertness" protocol to investigate: 
1) relative changes in EEG measures throughout the entire course of neurofeedback, 
2)  success of neurofeedback over 12 sessions could be shown through IVA+Plus 
(Braintrain Inc, VA) and Aberrant Behavior Checklist (ABC) (Aman and Singh 
1994) measures,   
3) and most importantly, how EEG power ratios are changing and how the changes 
correlated with measures of "Focus" and "Alertness."  
     A number of expectations were held prior to the study. It was expected that all 
participants would complete 12 sessions of "Focus/Alertness" training and learn to 
control “Focus” and “Alertness” parameters in biofeedback mode.  Additionally, it was 
expected that there would be an improvement in the clinical (ABC) and 
neuropsychological (IVA+Plus) measures as previously reported in the treatment of 
ADHD in neurofeedback.  It was expected that an improvement in "Focus" would 
manifest in the gradual decrease of the Theta/Beta EEG ratio.  As more of an exploratory 
aim, it was planned to analyze correlations between the "Focus" measures with specific 
EEG relative powers and proportions.  Finally, MatLab (Mathworks, Inc. MA) would be 
used to code an application that could effectively and efficiently analyze and compute all 
the desired measures. 
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II. DATA COLLECTION 
 
A. Subject Demographics and Recruitment 
Eighteen children and adolescents with ADHD (mean age 13.6 years, SD=3.5, 6 
female, 12 males) were enrolled in this study. Participating subjects and their parents 
were provided with all information about this study purposes and the consent/assent 
forms were signed.  During the course of the study, only 4 subjects were not taking 
stimulant medication. Participants were not required to be off medication during the 
course of neurofeedback training; however, all participants were requested to not take 
medication before their neurofeedback session on a day of visit. Participants with ADHD 
were recruited through the University of Louisville Weisskopf Child Evaluation Center 
(WCEC). Diagnosis was made according to the DSM-IV-TR and was further ascertained 
by Dr. Sears through a clinical interview.  In addition to diagnosis, Dr. Sears performed 
pre- and post-neurofeedback clinical evaluations. Neurofeedback sessions were 
conducted by Dr. Sokhadze.  All required IRB-approved consent/assent forms were 
signed by the participants and parent/guardian of the participating subjects. 
 
B. Neurofeedback Protocol and Data Recording 
 
This study involved the use of existing neurofeedback protocols to train the measures 
of "Focus" and "Alertness".  Subjects completed sessions using a "Focus/Alertness" 
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protocol designed to train the "Focus" and "Alertness" measures.  The goal of each 
subject was to enhance "Focus" throughout the session while maintaining an adequate 
measure of "Alertness" within a certain range.  All sessions were completed using 
different fragments of documentary films depicting nature scenes from the BBC “Planet 
Earth” and “Life” series.  Different scenes were utilized to maintain the engagement and 
motivation of participants.  Based on the thresholds set, the subject would receive 
biofeedback both in the visual and auditory modalities.  Visual feedback was arranged in 
a form of control of brightness, size, and continuation of the documentary by the “Focus" 
and "Alertness” measures.  For instance, based on processing of "Focus" and "Alertness" 
measures in real time, the video feed will shrink or enlarge and fade or become brighter.   
Auditory feedback was used to inform subjects when these measures were under the 
threshold level, in the case of "Focus", or outside the acceptable range, in the case of 
"Alertness".   Figure 1 illustrates a sample interface seen by a subject during a 
neurofeedback session. 
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FIGURE 1: Sample Neurofeedback interface as seen by a patient during a neurofeedback 
session showing the EEG signal with DVD video embedded in screen. 
 
All EEG signals and training parameters were measured from the same sensors, one 
active electrode at the prefrontal EEG (FPz) site and the second a reference on the left ear 
with a third sensor serving as a ground at the right earlobe. The sensors were soaked in a 
potassium chloride solution, compatible to concentration of salt in medical saline 
solution.  The setup (e.g. sensor placement, monitor placement, patient orientation, etc.) 
for each neurofeedback session is shown in Figure 2. 
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FIGURE 2: The setup is shown for a subject undergoing neurofeedback.  The image 
clearly illustrates the positioning of sensors, subject, and monitor 
 
Each subject completed a minimum of 12 weekly neurofeedback sessions.  The goal, as 
explained to each subject, was the training of an increase in "Focus" using the 
"Focus/Alertness" protocol.  The target length of each session recorded was 25 min, with 
most sessions reaching 20-min minimum length goal (n= 185 sessions out of 216 total 
sessions), with the shortest session recorded containing only 15 minutes of data.  Eye 
blink artifacts removal was implemented using a custom made BioExplorer (BioExplorer 
1.5, CyberEvolution, WA) application. 
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C. Clinical and Neuropsychological Measures of ADHD 
 
1. Clinical Measures and Evaluation 
 
In conjunction with neurofeedback, clinical measures along with pre- and post-
neurofeedback data were collected.  A clinical behavioral outcome measures in ADHD 
patients included scores from the Aberrant Behavior Checklist (ABC). The ABC is a 
rating scale assessing five problem areas: Irritability, Lethargy/Social Withdrawal, 
Stereotypy, Hyperactivity, and Inappropriate Speech, and is based on caregiver reports 
(Aman and Singh 1994).  Scoring of the ABC reports was completed by Dr. Sears. 
 
2. Neuropsychological Measures and Evaluation 
 
In addition to the collection of clinical measures, commonly accepted 
neuropsychological measures of selective attention were collected.  The continuous 
performance IVA+Plus (BrainTrain Inc, VA) selective attention test was administered 
before and after the 12 session "Focus/Alertness" neurofeedback course. This 20-min 
long test provides accurate measures of sustained auditory and visual attention quotients 
and is widely accepted as an acceptable neurocognitive test of attention in children 
(Sandford 2009). 
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III. Data Processing and Analysis 
 
A.  EEG Signal Processing 
 
1. BioReview 
 
As previously stated, the EEG signal was collected and recorded with 
BioExplorer-based software application.  The first goal of signal processing was to 
separate the raw signal based on the desired frequency bands.  The first step in the 
filtering process was completed in BioReview – an extension of BioExplorer that serves 
for analysis of recorded sessions.  The frequency ranges for each selected band are 
similar to, yet a slight modification of those described by Miller (2007).  The signal was 
separated into Delta (2-4 Hz), Theta (4-8 Hz), Alpha (8-13 Hz), Low Beta (13-18 Hz), 
High Beta (18-30 Hz), and Gamma (30-45 Hz) components using a band-pass filter with 
a Harris window configuration.  Additionally, the raw signal was exported for later use if 
additional filtering would be needed. The report design in BioReview is based on a 
Visual Basic design.  Each filter is added to the report block diagram and then the 
settings of the filter are customized and edited according to what is desired.  Figure 3 
shows the layout of the block diagram designed for this application.   
 
 
17 
 
 
Figure 3: BioReview report block diagram with filters for each EEG band collected [, 
Delta (2-4 Hz), Theta (4-8 Hz), Alpha (8-13 Hz), Low Beta (13-18 Hz), High Beta (18-30 
Hz), Gamma (30-45 Hz)].  The raw signal is output once the report is run. 
 
 
Each session was processed using this report.  The sampling rate for all data was 256 Hz.  
After processing through the BioReview report, each session was exported as raw data.  
In this configuration, every data point was exported to a text file where the different 
measures were organized into columns and each subsequent row represented the change 
in time between samples.  
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2. MatLab 
 
 After exporting the text file from BioReview, the data was then to be analyzed 
and processed in MatLab.  Based on the nature of the neurofeedback system, it was 
determined that relative power comparisons between bands would be appropriate for this 
analysis.  For instance, the system used in neurofeedback did not have a calibration 
measure.  As a result, of this lack of calibration it was decided power measures were 
more appropriate based on an assumption of constant resistance within the system instead 
of assuming the system measured voltage consistently across all subjects.  Through this 
assumption of equivalent resistance based on constant wire length, wire gauge, 
thermostat controlled temperature (at room temperature) of lab where neurofeedback 
occurred, and uniformity in the EEG sensors used across all subjects the relative power 
equation could be simplified. As can be seen in equation 1 showing the traditional 
calculation of power in electrical signal, resistance is present.   
 
                      (1) 
 
However, resistance being constant across each session would allow for the removal of 
that term in any relative power calculation.  This is pertinent since the exact resistance of 
the system is not known for each session. 
Therefore, it was necessary to filter in MatLab from 2-45 Hz to gain the total 
power of the band of interest.  To complete the filtering necessary for completion of the 
19 
 
analysis, MatLab code was designed using a custom band-pass filter application created 
through the integration of wavelet transformation of the raw signal (effective for handling 
any noise in the signal) and a Harris window configuration that separates the 2-45 Hz 
portion of the raw signal into its own filtered signal.  Therefore, band-pass filtering of the 
raw signal in MatLab provided a "total" signal (2-45 Hz) that could then be utilized in 
relative power calculations.   
After filtering of the raw signal to the desired frequency, relative power 
calculations for each minute of every neurofeedback session were completed in MatLab 
using an iterative for loop function on each recorded session with the filtered total signal 
of interest replacing the raw signal.  The formula used to calculate relative power in this 
analysis is given in Equation 2, where b represents the band signal and t represents the 
"total" signal from 2-45 Hz.   
 
              (2) 
 
The summation includes every data point for 1 minute of recorded data, 15360 data 
points per minute based on a 256 Hz sampling rate.  Therefore, an average relative power 
for each band was calculated for each minute of each session.  It is important to note that 
since relative power was investigated instead of relative amplitude, that the calculated 
measure is not a pure percentage and will not be labeled as such.   In addition to the 
calculation of relative power for each band, the ratio of certain bands was calculated 
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using the relative power values calculated for each band. The formula for calculating the 
ratios of certain bands is given in Equation 3.   
 
                  (3) 
 
Therefore, the band ratio was calculated for each minute of each session. The ratios of 
interest for this study were the Theta/Low Beta, Theta/High Beta, Theta/Beta, and 
Theta/Alpha proportion.  Theta/Beta ratio was calculated using the sum of the Low Beta 
and High Beta relative powers for each minute, but otherwise the formula in Equation 3 
was followed.  
Initially, each session for each subject was analyzed independently and output 
into an Excel summary file for that subjects' session.  However, the goal of the research 
involved a deeper look into EEG changes according to minute and session of 
neurofeedback.   Therefore, to differences between subjects were assumed to be normal 
during each minute of each session of neurofeedback.  This facilitated the averaging of 
EEG measures across subjects which made possible a more intensive analysis of session 
number and minute number of neurofeedback possible.  In order to gain single output 
files for each session of neurofeedback, a cell array configuration was utilized in MatLab 
where each session for each individual subject was placed in a row of the array 
corresponding to session number.  Then session 1 averages for all measures were 
calculated across the row according to minute and number of sessions with data at that 
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minute of neurofeedback.  Figure 4 uses a block diagram setup to illustrate the concept 
utilized for this method of data processing.   
 
FIGURE 4: Block Diagram to demonstrate MatLab coding for cell array.  Each 
subsequent row in the array represents the subsequent session.  Each column represents 
an additional subject.  The mean for each session is calculated by summing across each 
row of the cell array to determine the mean of the EEG measures for each minute of 
neurofeedback within that session. 
 
The end result of the data processing was twelve Microsoft Excel files output according 
to session number with essentially the summary data for each measure (organized by 
columns) at each minute of neurofeedback. 
 
B. Statistical Analysis 
Statistical analysis techniques were utilized to determine the significance of 
session number (1-12) and minute (1-25) with regards to each EEG measure calculated.  
A General Linear Model ANOVA was utilized with α=0.05 to determine significant 
changes in each EEG band, band ratio, and “Focus/Alertness” measures.  Potential linear 
correlations between session and minute averages of "Focus" and other significant EEG 
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measures were investigated using the Pearson Correlation statistic with α=0.05 for 
significance.  Additionally, student's two tailed t-test (α=0.05) was used to determine 
significant changes between pre- and post- data collected through the IVA+ tests and the 
ABC survey. Statistical analysis was conducted using MiniTab16.0 (State College, PA) 
and SPSS v.15 software (SPSS, Inc., IL).   
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IV. RESULTS 
 
A. EEG Measures changes by Session 
The ANOVA supported that there were main effects of session for all interested 
EEG measures.  Specifically, the effect of session was determined to be significant for  
Theta relative power [F(11,264) = 6.96, p-value<0.001], Low Beta relative power 
[F(11,264) = 6.85, p-value<0.001],  Theta/Low Beta ratio [F(11,264) = 9.02, p-
value<0.001], Theta/Alpha ratio [F(11, 264) = 19.74 , p-value< 0.001], and "Focus" 
[F(11,264) = 32.39, p-value<0.001]. The full summary of the ANOVA results for 
changes in EEG measures from session 1-12 are presented in Table 1.   
TABLE I 
 
SUMMARY OF ANOVA RESULTS FOR CHANGES IN EEG MEASURES FROM SESSION 
1-12 OF NFB (P<0.05 SIGNIFICANT) 
 
 
EEG Measure 
Degrees of 
Freedom 
F-
Statistic 
p-
value 
Direction of 
Change 
Delta Relative Power 11 8.03 <0.001 Decrease 
Theta Relative Power 11 6.96 <0.001 Decrease 
Alpha Relative Power 11 7.74 <0.001 Increase 
Low Beta Relative Power 11 6.85 <0.001 Increase 
High Beta Relative Power 11 5.67 <0.001 Decrease 
Gamma Relative Power 11 5.97 <0.001 Decrease 
Theta/Low Beta Ratio 11 9.02 <0.001 Decrease 
Theta/High Beta Ratio 11 7.64 <0.001 Decrease 
Theta/Beta Ratio 11 7.49 <0.001 Decrease 
Theta/Alpha Ratio 11 19.74 <0.001 Decrease 
"Focus" Measure 11 32.39 <0.001 Increase 
"Alertness" Measure 11 3.85 <0.001 Decrease 
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Changes were determined to be either increasing or decreasing based on the trend the 
data exhibited when charted.  Therefore, from session 1-12 Theta relative power, 
Theta/Low Beta ratio, and Theta/Alpha ratio are shown to be significantly decreasing.  
An increase is seen from session 1-12 with Low Beta relative power and "Focus" 
measure.  Changes in Theta/Low Beta ratio, Theta/Alpha ratio, and "Focus" measure 
were of particular interest.  To gain an understanding of the relationship between changes 
in session number and these measures, the average value for each session of each EEG 
measure were plotted from session 1-12.  Figures 5-7 display the change in average 
Theta/Low Beta ratio, Theta/Alpha ratio, and "Focus" measure, respectively, from 
session 1-12.   A linear relationship is the most obvious fit for average changes from 
session 1-12.  
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FIGURE 5: Plot of average Theta/Low Beta ratio value for each session (session number 
1-12) indicating a decrease in the value of Theta/Low Beta ratio as session number 
increases.  R
2
 value and equation for linear relationship included on the plot. 
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FIGURE 6: Plot of average Theta/Alpha ratio value for each session (session number 1-
12) indicating a decrease in the value of Theta/Alpha ratio as session number increases.  
R
2
 value and equation for linear relationship included on the plot. 
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FIGURE 7:  Plot of average "Focus" value for each session (session number 1-12) 
indicating an increase in the value of "Focus" as session number increases.  R
2
 value and 
equation for linear relationship included on the plot. 
 
B. EEG Measures changes by Minute 
The ANOVA supported that there were main effects of minute for some interested 
EEG measures.  Specifically, the effect of minute was determined to not be significant for 
Theta relative power [F (24,264) = 0.98, p = .493] or Low Beta relative power [F 
(24,264) = 0.88, p = .633].  However, the Theta/Low Beta ratio [F (24,264) = 2.12, p = 
0.002], Theta/Alpha ratio [F (24,264) = 2.05, p = 0.003], and "Focus" measure [F 
(24,264) = 4.35, p<0.001] were shown to change significantly according to minute. The 
full summary of the ANOVA results for changes in EEG measures from minute 1-25 are 
presented in Table 2.  
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TABLE II 
 
SUMMARY OF ANOVA RESULTS FOR CHANGES IN EEG MEASURES FROM 
MINUTE 1-25 OF NFB WITHIN A SESSION (P<0.05 SIGNIFICANT) 
 
EEG Measure 
Degrees of 
Freedom 
F Statistic 
p-
value 
Direction of 
Change 
Delta Relative Power 24 1.64 0.032 Decrease 
Theta Relative Power 24 0.98 0.493 NS 
Alpha Relative Power 24 0.710 0.841 NS 
Low Beta Relative Power 24 0.88 0.633 NS 
High Beta Relative Power 24 1.58 0.045 Increase 
Gamma Relative Power 24 1.66 0.029 Increase 
Theta/Low Beta Ratio 24 2.12 0.002 Decrease 
Theta/High Beta Ratio 24 6.11 <0.001 Decrease 
Theta/Beta Ratio 24 4.82 <0.001 Decrease 
Theta/Alpha Ratio 24 2.05 0.003 Decrease 
"Focus" Measure 24 4.35 <0.001 Increase 
"Alertness" Measure 24 4.83 <0.001 Increase 
 
 
 
 
 
 
Changes were determined to be either increasing or decreasing based on the trend the 
data exhibited when charted.  Therefore, from minute 1-25 Theta/Low Beta ratio and 
Theta/Alpha ratio was shown to be significantly decreasing.  An increase is seen from 
minute 1-25 with "Focus" measure.  As with the changes seen across sessions, changes in 
Theta/Low Beta ratio, Theta/Alpha ratio, and "Focus" measure across minute of session 
were of particular interest.  To gain an understanding of these changes in Theta/Low Beta 
ratio, Theta/Alpha ratio, and "Focus" measure depending on minute of neurofeedback 
session, the average value for each minute of each EEG measure were plotted from 
minute 1-25. Figures 8-10 display the changes in average Theta/Low Beta ratio, 
Theta/Alpha ratio, and "Focus" measures, respectively, from minute 1-25.   With regard 
to changes within a session of neurofeedback, a logarithmic relationship was deemed to 
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be a better fit than a linear relationship.  For instance, in addition to visual inspection, the 
R
2
 value for a linear relationship between "Focus" measure and minute (R
2
=0.3281) was 
much lower than the R
2 
value seen in Figure 10 associated with the logarithmic 
relationship. 
 
FIGURE 8: Plot of average Theta/Low Beta ratios (averaged across all sessions) for each 
minute of Neurofeedback (1-25) indicating a decreasing Theta/Low Beta ratio as minute 
of NFB within a session increases.  R
2
 value and equation for logarithmic relationship 
included on the plot. 
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FIGURE 9: Plot of average Theta/Alpha ratios (averaged across all sessions) for each 
minute of Neurofeedback (1-25) indicating a decreasing Theta/Alpha ratio as minute of 
NFB within a session increases.  R
2
 value and equation for logarithmic relationship 
included on the plot. 
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FIGURE 10: Plot of average "Focus" values (averaged across all sessions) for each 
minute of Neurofeedback (1-25) indicating an increasing "Focus" measure as minute of 
NFB within a session increases.  R
2
 value and equation for logarithmic relationship 
included on the plot. 
 
 
C. Correlation between "Focus" Measure and EEG Band Relative Powers/Ratios 
The results of the Pearson Correlation, using the corresponding average values for 
any interested EEG measures (Theta relative power, Alpha relative power, Low Beta 
relative power, High Beta relative power, Theta/Low Beta ratio, Theta/High Beta ratio, 
Theta/Beta ratio, and Theta/Alpha ratio) and for "Focus" calculated for changes in minute 
1-25 and session 1-12, showed possible correlations in multiple EEG band relative power 
and EEG band ratios with the "Focus" measure.    Specifically, a significant correlation 
existed between "Focus" and the Theta/Low Beta ratio (Pearson Correlation Coefficient = 
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-0.633, p<0.001, R
2
 = 0.401).  Additionally, a significant correlation existed between 
"Focus" and the Theta/Alpha ratio (Pearson Correlation Coefficient = -0.676, p<0.001, R
2
 
= 0.457). Table 3 fully summarizes the results of the Pearson Correlation test and gives 
the linear regression equation of the correlation between all significant measures and the 
"Focus" measure with appropriate R
2
 values.   
 
 
 
 
TABLE III 
 
SUMMARY OF RESULTS OF PEARSON CORRELATION TEST USING 
CORRESPONDING AVERAGE VALUES OF EEG BAND RELATIVE POWERS 
AND EEG BAND RATIOS WITH "FOCUS" MEASURE (P<0.05 SIGNIFICANT) 
 
  Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Theta/ 
Low Beta 
Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ 
Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" 
 
Pearson 
Correlation 
Coefficient 
 
-0.197 0.444 0.423 0.373 -0.633 -0.577 -0.612 -0.676 
 
p-value 
 
0.242 0.006 0.009 0.023 <0.001 <0.001 <0.001 <0.001 
 
 
Equation 
 
 
y =             
-68.179x + 
80.618 
y = 
194.17x + 
69.304 
y = 
283.31x + 
70.576 
y =    
76.68x + 
72.227 
y =           
-1.5496x 
+ 85.584 
y =             
-1.2722x + 
80.056 
y =               
-2.7701x 
+ 81.765 
y =              
-3.9262x 
+ 87.736 
 
R2 Value 
 
0.0389 0.1968 0.1792 0.1388 0.4005 0.3334 0.3742 0.4573 
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Additionally, Figure 11 plots the correlation for the Theta/Low Beta ratio vs. "Focus," 
while Figure 12 plots the correlation for the Theta/Alpha ratio vs. "Focus."  
 
FIGURE 11:  Plot of correlation between corresponding average "Focus" values and 
Theta/Low Beta ratios for Sessions 1-12 and Minute 1-25 of NFB within a session. 
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FIGURE 12: Plot of correlation between corresponding average "Focus" values and 
Theta/Alpha ratios for Sessions 1-12 and Minute 1-25 of NFB within a session. 
 
D. IVA+ and ABC Survey – Pre- and Post-Neurofeedback 
The student t-test performed on the results of the IVA+ yielded multiple measures 
showing a significant change from pre- to post-neurofeedback for each subject.  The 
Attention Quotient showed a significant change from pre-neurofeedback (78.00 ± 6.33) 
to post-neurofeedback (87.22 ± 5.68); t (17) = -2.576, p = 0.020. The Attention Quotient 
– Visual showed a significant change from pre-neurofeedback (89.89 ± 4.40) to post-
neurofeedback (97.89 ± 3.31); t (17) = -2.285, p = 0.035. The Sustained Visual Attention 
Quotient showed a significant change from pre-neurofeedback (83.44 ± 5.64) to post-
neurofeedback (97.83 ± 4.92); t (17) = -2.721, p = 0.015. The Visual Reaction Time (ms) 
showed a significant change from pre-neurofeedback (490.78 ± 22.87) to post-
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neurofeedback (468.94 ± 19.45); t (17) = 2.379, p = 0.029.  Table 4 fully summarizes the 
IVA+ t-test results. 
 
TABLE IV 
 
SUMMARY OF SIGNIFICANT CHANGES WITHIN THE IVA+PLUS TEST FROM 
COMPARING PRE- AND POST- NEUROFEEDBACK (P<0.05 SIGNIFICANT) 
 
Measure 
Pre-NFB 
Mean ± 
SE 
Post-NFB 
Mean ± 
SE 
t-statistic p-value 
Change from 
Pre-NFB to 
Post-NFB 
Attention Quotient 
 
78.00 ± 
6.33 
 
87.22 ± 
5.68 
-2.576 0.020 Increase 
Attention Quotient – 
Auditory 
 
70.39 ±  
7.62 
 
79.06 ± 
7.94 
-2.012 0.060 NS 
Attention Quotient – 
Visual 
 
89.89 ± 
4.40 
 
97.89 ± 
3.31 
-2.285 0.035 Increase 
Sustained Auditory 
Attention Quotient 
 
60.83 ± 
9.44 
 
74.11 ± 
9.41 
-2.009 0.061 NS 
Sustained Visual 
Attention Quotient 
 
83.44 ± 
5.64 
 
97.83 ± 
4.92 
-2.721 0.015 Increase 
Auditory Reaction 
Time (ms) 
 
735.56 ± 
30.54 
 
699.00 ± 
31.98 
1.812 0.088 NS 
Visual Reaction Time 
(ms) 
 
490.78 ± 
22.87 
 
468.94 ± 
19.45 
2.379 0.029 Decrease 
 
 
All ABC survey measures showed significant changes from pre- to post-
neurofeedback.  Specifically, Hyperactivity and Inappropriate Speech showed the most 
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significant changes.  Hyperactivity showed a significant change from pre-neurofeedback 
(15.28 ± 3.24) to post-neurofeedback (10.83 ± 2.44); t (17) = 3.189, p = 0.005.  
Inappropriate Speech showed a significant change from pre-neurofeedback (2.94 ± 0.75) 
to post-neurofeedback (1.94 ± 0.64); t (17) = 4.675, p<0.001. Table 5 fully summarizes 
the results of the t-test for the ABC outcomes.   
TABLE V 
 
SUMMARY OF SIGNIFICANT CHANGES IN CLINICAL MEASURE AS 
INDICATED BY THE ABBERANT BEHAVIOR CHECKLIST SURVEY FROM 
COMPARING DATA FROM PRE- AND POST- NEUROFEEDBACK (P<0.05 
SIGNIFICANT) 
 
Measure 
Pre-NFB 
Mean ± 
SE 
Post-NFB 
Mean ± 
SE 
t-statistic p-value 
Change from 
Pre-NFB to 
Post-NFB 
Irritability 
 
11.67 ± 
2.16 
 
8.33 ± 
2.01 
3.602 0.002 Decrease 
Lethargy 
 
8.00 ± 
2.04 
 
3.94 ± 
1.25 
2.366 0.030 Decrease 
Stereotypy 
 
3.89 ± 
1.37 
 
2.56 ± 
1.01 
2.515 0.022 Decrease 
Hyperactivity 
 
15.28 ± 
3.24 
 
10.83 ± 
2.44 
3.189 0.005 Decrease 
Inappropriate Speech 
 
2.94 ± 
0.75 
 
1.94 ± 
0.64 
4.675 <0.001 Decrease 
 
 
 
37 
 
 
 
V. CONCLUSIONS 
 
The results outlined in Tables 1 and 2 indicate outcomes which were primarily 
expected with regards to changes in the relative power of interested bands and the change 
in ratios. For instance, the Theta band is shown to decrease across sessions and minute 
within a session, while the Alpha band is shown to increase for both criteria. Therefore, it 
would appear that the Theta/Alpha band should decrease for both session and minute 
within a session. This is evidenced in Figure 6 and 9. However, several bands (High Beta 
and Gamma) and “Alertness” measure show what appear to be counterintuitive results at 
first glance. Upon further inspection of the protocol and the changes within each band 
though, this discrepancy can be rationalized and explained. The High Beta band shows an 
increase in relative power within session, but a decrease from session to session. 
However, the session to session changes indicate a very low correlation. Additionally, 
neurofeedback doesn't specifically target the 18-30 Hz range encompassed by the High 
Beta designation in this protocol. The Gamma measure is also not noted for being 
specifically targeted by this application. However, the increase within session observed in 
the Gamma range could be the result of an increase in a subjective sense of achievement 
attained through mastery of the assigned skill (i.e. increasing ability to focus attention). It 
has been suggested that an increase in the prefrontal Gamma activity could be tied to 
emotional responses and the effort associated with learning (Rubik 2011). Therefore, the 
decrease in Gamma activity from session to session could be the result of the subject 
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having a lower effort to mastering this skill of concentration of attention. Finally, 
"Alertness" indicates a decrease from session 1-12, while indicating an increase from 
minute 1-25 within a session. This is not unexpected since "Alertness" was not to be 
enhanced or suppressed in this protocol, but simply maintained within a broad range. In 
the later stages of the neurofeedback training course the ability to focus attention does not 
require general arousal, resulting in dissociation of two measures and lower correlation of 
“Focus” and “Alertness”. 
As evidenced in Tables 1-2 and Figures 5, 6, 8, and 9 the most notable indications 
of this analysis are a decrease in the Theta/Low Beta and Theta/Alpha proportions from 
session to session and from minute 1 to minute 25 within a session. These results show 
consistency with the overall aims and goals of neurofeedback which have been described 
earlier (Monastra 2005). Specifically, this claim can be made regarding the decrease in 
the Theta/Low Beta ratio. A net reduction in Theta/Low Beta ratio was seen across both 
sessions and minute within a session. These findings support the treatment of EEG 
irregularities within the ADHD population (Barry, Clarke, and Johnstone 2003) with 
neurofeedback techniques. Figure 13 provides visual illustration of the observed changes, 
as a result of session number and minute within a session, through utilization of a surface 
chart representing a three dimensional view of the data.  
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FIGURE 13:  The surface chart provides evidence supporting the decrease in the 
Theta/Low Beta ratio with regards to increasing session number and increasing minute of 
each session.  As is consistent with the results of the ANOVA, Session trends, and 
Minute trend analysis, a general decrease is seen from (Session 1, Minute 1) through 
(Session 12, Minute 25) for the Theta/Low Beta ratio.  The legend on the right side of the 
figure gives the color-coded ranges for the Theta/Low Beta ratio, as seen in the chart. 
 
 In this study, the Theta band was characterized by the EEG signals collected between 4-8 
Hz whereas the Alpha signal was characterized via the signals collected between 8-13 
Hz. A reduction in the Theta/Alpha proportion was seen across both sessions and minute 
within a session. As with the evidence provided for changing Theta/Low Beta ratio 
values, visual illustration of a decrease in Theta/Alpha ratio as a function of session 
number and minute within a session is provided in Figure 14.   
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FIGURE 14: The surface chart provides evidence supporting the decrease in the 
Theta/Alpha ratio with regards to increasing session number and increasing minute of 
each session.  As is consistent with the results of the ANOVA, Session trends, and 
Minute trend analysis, a general decrease is seen from (Session 1, Minute 1) through 
(Session 12, Minute 25) for the Theta/Alpha ratio.  The legend on the right side of the 
figure gives the color-coded ranges for the Theta/Alpha ratio, as seen in the chart. 
 
Also, the decrease of Theta/Alpha and Theta/Low Beta ratios indicate a potential link 
between these ratios and the targeted desynchronized measure of "Focus" recorded at the 
prefrontal site, since "Focus" showed an increase across session number and minute 
within a session (Fig. 15). 
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FIGURE 15: The surface chart provides anecdotal evidence supporting the increase in the 
"Focus" measure with regards to increasing session number and increasing minute of 
each session.  As is consistent with the results of the ANOVA, Session trends, and 
Minute trend analysis, a general increase is seen from (Session 1, Minute 1) through 
(Session 12, Minute 25) for the "Focus" measure.  The legend on the right side of the 
figure gives the color-coded ranges for the "Focus" measure, as seen in the chart. 
 
As previously mentioned, ADHD subjects, especially subjects presenting with Inattentive 
ADHD subtype, have similar expressions of EEG characteristics. This is specifically 
evident in the Theta/Beta proportion being similar in the first session to that encountered 
in other studies involving ADHD subjects (Barry et al. 2009; Lansbergen et al. 2011; 
Ogrim, Kropotov, and Hestad 2012). In this analysis, the average session one value for 
the Theta/Low Beta proportion was 7.4, which is similar to the baseline value of 6.4-6.6 
reported by Monastra (2008) for Theta/Beta values encompassing similar frequencies 
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current data of Ogrim, Kropotov, and Hestad  (2012) ( 7.02-7.08 for young ADHD group 
and 6.21for adult ADHD group). 
Due to the improvements in clinical and functional outcomes indicated through 
IVA+Plus and ABC, there is also discussion to be held as to whether training of the 
"Focus" measure or the Theta/Beta and Theta/Alpha ratios are more fundamental to 
functional improvement.  Determination of the measure more fundamental to treatment of 
ADHD would increase the efficiency and aid in the delivery of neurofeedback treatment 
methods.  
Similar to prior work in the treatment of ADHD with neurofeedback, this study 
indicates the efficacy of neurofeedback for altering the EEG characteristics associated 
with the disorder (Arns et al. 2009; Gevensleben et al. 2009; Holtmann and Stadler 2006; 
Monastra 2005; Sherlin et al. 2010a, 2010b; Sokhadze 2012). The positive effects of the 
increase in "Focus" during neurofeedback corresponded to an improvement in the clinical 
measures and functional outcomes seen in the IVA+Plus test and the ABC survey. Since 
this exploratory study did not use a controlled design we are not claiming any clinical 
efficiency results, but rather consider it as an investigation of EEG bands' relative powers 
and their ratios across 12 session neurofeedback training course aimed to enhance 
focused attention. This is a methodological study that uses EEG analysis in ADHD 
children enrolled in neurofeedback treatment using a specialist device and software.  
However, this analysis differs from those prior studies in the consideration of 
what is transpiring not only from session to session, but also within each session. 
Therefore, improvement can be indicated within a shorter number of sessions (i.e. 12) 
compared to previous protocols that required 30-40 sessions per subject to statistically 
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indicate significant improvement either in EEG or clinical behavioral measures 
(Gevensleben et al. 2009). Probably more than 12 sessions might contribute to better 
consolidation of results of operant conditioning using neurofeedback and currently we 
have study in progress that will compare outcomes of 12 vs. 18 sessions of 
neurofeedback using the same protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
 
 
VI. FUTURE WORK AND APPLICATIONS 
 Based on the application developed for more efficiently processing data from 
neurofeedback sessions, a great deal of future research is brought to the forefront of 
discussion.  The first extension of this research involves the use of a controlled study to 
demonstrate these changes.  In this study, the results clearly demonstrated changes in 
certain bands and band ratios during neurofeedback even though specific bands were not 
targeted in the protocol.  Therefore, a study incorporating a control group of non-ADHD 
subjects contrasted with a group consisting of ADHD subjects with each group 
undergoing neurofeedback sessions to increase "Focus" would be beneficial.  The ADHD 
group could be further broken down into positive and negative for comorbid diagnosis, or 
medicated vs. non-medicated subjects.  Additionally, one shortcoming of the current 
study involved the use of a neurofeedback system without a calibration measure.  In a 
controlled study, a system with calibration capabilities would increase the ability for a 
wide-ranging analysis.  Assumptions based on resistance, derived from general electrical 
principles, could be bypassed and the true total power of the EEG signal could be 
calculated and compared across different subjects with regard to session and minute of 
neurofeedback.  Other measures such as relative amplitude of the signal in bands and 
band ratios could also be more accurately considered. 
 This study also utilized band-pass filtering to analyze the differences and changes 
within EEG bands and band ratios.  Band-pass filtering, although with its advantages, 
does have larger affinity for error due to multiple filters being necessary to develop the 
interested relative powers and band ratios.  A spectral analysis of each could produce 
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results with greater accuracy than seen with a band-pass based analysis.  Spectral analysis 
would involve only filtering the signal from 2-45 Hz and then calculating power of 
measures from the integration of the results expressed in the frequency domain following 
a fast Fourier transform (FFT).   
 In addition to changing the form of analysis, there is also a viable extension of 
this protocol to a different patient population.  Many neurophysiological disorders present 
with abnormal EEG patterns (Pliszka 1998).  As a result, an extension of this protocol to 
autistic subjects seems logical.  Such a study would be the first of its kind to examine the 
EEG changes occurring within neurofeedback treatment of autistic subjects.  Results of 
this analysis would be integral to determine any efficacy or benefit of treatment of autism 
with neurofeedback protocols. 
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APPENDIX I: MATLAB CODES 
 
 
 
 
A. EEG Signal Processing Main Code 
 
 
clear 
close all 
clc 
 
mkdir('Output_Excel_Files'); 
xlsDir_Input = [cd '\Converted\'];       % Input data folder 
xlsDir_Output =[cd '\Output_Excel_Files\'];     % Output data folder 
 
allXls_Files = dir(xlsDir_Input); %Structure with all files in the specified dir. 
FL = length(allXls_Files);        %Total # of files inncludes hidden ones 
for file_number =1:FL 
if strcmp(allXls_Files(file_number).name,'.') || 
strcmp(allXls_Files(file_number).name,'..') || 
strcmp(allXls_Files(hh).name,'Thumbs.db') 
continue;                             % Avoid all  hidden files in folder 
end 
curFile = allXls_Files(file_number).name; 
  
Input_Chs = dlmread([xlsDir_Input, '\' curFile ], ',', 2, 0); 
Input_Chs = Input_Chs(:,1:7); 
if size(Input_Chs,1)>=25*256*60 %To only look at first 25 minutes of file 
Raw_Signal = Input_Chs(1:25*256*60,1);   
else  
Raw_Signal = Input_Chs(:,1); 
end 
max_value = max(max(Raw_Signal)); 
min_value = min(min(Raw_Signal)); 
     
c = cwt(Raw_Signal,[1:1:128],'morl');    %Continuous Wavelet Transformation 
Inp_S_2_45 = Input_Signal_2_45(c); %Input Signal 2-45 Hz Function 
for k = 1:1:length(Inp_S_2_45) 
 if Inp_S_2_45(k)>max_value 
            Inp_S_2_45(k) = max_value; 
      end 
         
     if Inp_S_2_45(k)<min_value 
             Inp_S_2_45(k) = min_value; 
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     end 
end 
     
Delta_Signal = Input_Chs(:,2); 
Theta_Signal = Input_Chs(:,3); 
Alpha_Signal = Input_Chs(:,4); 
Low_Beta = Input_Chs(:,5); 
High_Beta = Input_Chs(:,6); 
Gamma_Signal = Input_Chs(:,7); 
     
No_Minutes = fix((length(Inp_S_2_45))./15360) 
for k = 1:1:No_Minutes 
        Start_In = (k-1).*15360 + 1; 
         End_In = k.*15360; 
D_S = Delta_Signal(Start_In:1:End_In); 
T_S = Theta_Signal(Start_In:1:End_In); 
A_S = Alpha_Signal(Start_In:1:End_In); 
L_B = Low_Beta(Start_In:1:End_In); 
H_B = High_Beta(Start_In:1:End_In); 
G_S = Gamma_Signal(Start_In:1:End_In); 
I_S = Inp_S_2_45(Start_In:1:End_In); 
         
R_D_S(k) = sum(D_S.^2)./sum(I_S.^2); 
R_T_S(k) = sum(T_S.^2)./sum(I_S.^2); 
R_A_S(k) = sum(A_S.^2)./sum(I_S.^2); 
R_L_B(k) = sum(L_B.^2)./sum(I_S.^2); 
R_H_B(k) = sum(H_B.^2)./sum(I_S.^2); 
R_G_S(k) = sum(G_S.^2)./sum(I_S.^2); 
         
Ratio_T_L_B(k) = R_T_S(k)./R_L_B(k); 
Ratio_T_H_B(k) = R_T_S(k)./R_H_B(k); 
Ratio_T_B(k) = R_T_S(k)./(R_L_B(k) + R_H_B(k)); 
Ratio_T_A(k)=R_T_S(k)./R_A_S(k) 
end 
Start_In = 1; 
End_In = No_Minutes.*15360; 
D_S = Delta_Signal(Start_In:1:End_In); 
T_S = Theta_Signal(Start_In:1:End_In); 
A_S = Alpha_Signal(Start_In:1:End_In); 
L_B = Low_Beta(Start_In:1:End_In); 
H_B = High_Beta(Start_In:1:End_In); 
G_S = Gamma_Signal(Start_In:1:End_In); 
 I_S = Inp_S_2_45(Start_In:1:End_In); 
R_D_S(No_Minutes + 1) = sum(D_S.^2)./sum(I_S.^2); 
R_T_S(No_Minutes + 1) = sum(T_S.^2)./sum(I_S.^2); 
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R_A_S(No_Minutes + 1) = sum(A_S.^2)./sum(I_S.^2); 
R_L_B(No_Minutes + 1) = sum(L_B.^2)./sum(I_S.^2); 
R_H_B(No_Minutes + 1) = sum(H_B.^2)./sum(I_S.^2); 
R_G_S(No_Minutes + 1) = sum(G_S.^2)./sum(I_S.^2); 
Ratio_T_L_B(No_Minutes + 1) = R_T_S(No_Minutes + 1)./R_L_B(No_Minutes + 1); 
Ratio_T_H_B(No_Minutes + 1) = R_T_S(No_Minutes + 1)./R_H_B(No_Minutes + 1)    
Ratio_T_B(No_Minutes + 1) = R_T_S(No_Minutes + 1)./(R_L_B(No_Minutes + 1) + 
 R_H_B(No_Minutes + 1)); 
Ratio_T_A(No_Minutes + 1)=R_T_S(No_Minutes +1)./R_A_S(No_Minutes + 1); 
  
X = [R_D_S' R_T_S' R_A_S' R_L_B' R_H_B' R_G_S' Ratio_T_L_B' Ratio_T_H_B' 
Ratio_T_B' Ratio_T_A']; 
curFile = curFile(1:end-4); 
xlswrite([ xlsDir_Output '\Result_' curFile '.xlsx'],X) 
end 
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B. Input Signal Filtering Function 
 
 
Input Signal 2_45 
function Filtered_Wav = Input_Signal_2_45(coefs) 
 
fs = 256; 
[h w] = size(coefs); 
 
for iter_index = 1:h 
xnoisy = coefs(iter_index,:); 
Filtered_Signal = BPF_2_45(xnoisy,fs); 
Filtered_Wav_coef(iter_index,1:w) = Filtered_Signal(1:w);  
end 
 
Filtered_Wav = sum(Filtered_Wav_coef)./128; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
C.  2-45 Hz Band-pass Filter Function 
 
 
BPF_2_45 
 
function Filtered_Signal = BPF_2_45(x,fs) 
 
% BPF Parameters 
Fp1= 2./fs; 
Fp2 = 45./fs; 
 
Fs1 = 0.5./fs; 
Fs2 = 46.5./fs; 
 
F0 = (Fp1 + Fp2)./2; 
 
Fp = 0.5.*(Fp2 - Fp1); 
Fs = 0.5.*(Fs2 - Fs1); 
 
Fc = (Fp + Fs)./2; 
C = 7.96;   % Assuming Harris Window 
Number_of_Samples = round(C./Fc); 
 
% To check that the number of samples are odd 
if ((Number_of_Samples./2)==fix(Number_of_Samples./2)) 
Number_of_Samples = Number_of_Samples +1; 
end 
N = [-(Number_of_Samples-1)./2:1:(Number_of_Samples-1)./2]; 
w_n = Harris_W_7(Number_of_Samples);  %Harris Window Function 
 
%Calculate the impulse response of LPF 
h_LPF = Impulse_Response_LPF(w_n,Fc);  %Impulse Response Function 
h_BPF = 2.*cos(2.*F0.*pi.*N).*h_LPF; 
 
 Y_C = conv(h_BPF,x); 
% To remove the transition time 
Filtered_Signal = Y_C(fix(Number_of_Samples./2):1:length(Y_C)-
fix(Number_of_Samples./2+1)); 
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D.  Harris Window Function 
 
 
function w_n = Harris_W_7(Number_of_Samples) 
 
b0 = 0.355768; 
b1 = 0.487396; 
b2 = 0.144232;  
b3 = 0.012604; 
 
i=0; 
for n = 0:1:(Number_of_Samples)-1 
i = i+1; 
w_n(i) = b0 - b1.*cos(2.*n.*pi./(Number_of_Samples-1)) + 
b2.*cos(4.*n.*pi./(Number_of_Samples-1)) - 
b3.*cos(6.*n.*pi./(Number_of_Samples-1)); 
end 
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E. Impulse Response LPF Function 
 
 
function h_LPF = Impulse_Response_LPF(w_n,Fc)  
 
n=0; 
N = length(w_n); 
 
for i = -(N-1)./2:1:(N-1)./2 
n = n+1; 
if (i==0) 
h(n) = 2.*Fc; %To calculate h[n] 
else 
h(n) = ((2.*Fc).*(sin(2.*Fc*pi*i)))./(2.*Fc.*pi.*i); 
end 
end 
h_LPF = h.*w_n; 
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F. Main Analysis Code  
 
 
%============================================================== 
clc;  
clear all; 
close all; 
%============================================================== 
mkdir('Outputs') 
parentDir=cd; 
allData_dir =[cd '\allData\']; 
OutDir = [cd '\Outputs\'];            % Output directory to save results 
  
dataFolders = dir(allData_dir); 
FL = length(dataFolders);      % Total # of subjects (Includes hidden folders) 
  
Ks =0; 
for file_number1 =1 : FL  %To determine # of subjects 
% take care of hidden files 
if strcmp(dataFolders(file_number1).name,'.') || 
strcmp(dataFolders(file_number1).name,'..') 
continue; 
end 
Ks = Ks+1; 
end 
  
patientCount = 0; 
  
allSelected_Sessions = cell(12, Ks); %Create Cell Array for 12 Sessions and Ks number 
%of subjects 
  
for file_number2 = 1 : FL      % To move from subject to subject for each session 
% take care of hidden files 
if strcmp(dataFolders(file_number2).name,'.') || 
strcmp(dataFolders(file_number2).name,'..') 
continue; 
end 
patientCount = patientCount + 1; 
% Current Data Set Directory and its Output Directory 
curFolder = dataFolders(file_number2).name; 
curData_dir = [allData_dir, curFolder ]; 
%=================================================== 
sessionFiles = dir(curData_dir); 
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FL2 = length(sessionFiles);   % Total # of Sessions (Includes hidden 
%folders) 
Ks2 = 0; 
for file_number3 =1 : FL    %To move from subject to subject while  
%getting FL2 session file 
% take care of hidden files 
if strcmp(sessionFiles(file_number3).name,'.') || 
strcmp(sessionFiles(file_number3).name,'..') 
continue; 
end 
Ks2 = Ks2 + 1; 
end 
 
allSessions = cell(1,Ks2); 
sessionCount = 0; 
for file_number4 = 1 : FL2  %To move from session to session across all  
%subjects 
% take care of hidden files 
if strcmp(sessionFiles(file_number4).name,'.') ||  
strcmp(sessionFiles(file_number4).name,'..') 
continue; 
end 
sessionCount = sessionCount + 1; 
% Current Data Set Directory and its Output Directory 
curFile = sessionFiles(file_number4).name; 
curData = xlsread([curData_dir '\' curFile]); 
allSessions{sessionCount} = curData; 
end 
%=================================================== 
%=================================================== 
allSelected_Sessions{1,patientCount} = allSessions{1}; 
allSelected_Sessions{2,patientCount} = allSessions{2}; 
allSelected_Sessions{3,patientCount} = allSessions{3}; 
allSelected_Sessions{4,patientCount} = allSessions{4}; 
allSelected_Sessions{5,patientCount} = allSessions{5}; 
allSelected_Sessions{6,patientCount} = allSessions{6}; 
allSelected_Sessions{7,patientCount} = allSessions{7}; 
allSelected_Sessions{8,patientCount} = allSessions{8}; 
allSelected_Sessions{9,patientCount} = allSessions{9}; 
allSelected_Sessions{10,patientCount} = allSessions{10}; 
allSelected_Sessions{11,patientCount} = allSessions{11}; 
allSelected_Sessions{12,patientCount} = allSessions{12}; 
end 
 
%The First Session 
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 ----------------- 
 first_Ses_Mean = zeros(25,10); 
 firstIndices =zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{1,cc}; 
[rows cols] = size(curPatient); 
%remove the summary row for each file  
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
first_Ses_Mean = first_Ses_Mean+curPatient; 
firstIndices = firstIndices + curIndx; 
end 
XX_01 = repmat(firstIndices,1,size(first_Ses_Mean,2)); 
first_Ses_Mean = firstSes_Mean./XX_01 ; 
xlswrite([OutDir '\first_Ses_Mean.xls'],first_Ses_Mean) 
  
% The Second Session 
%--------------------- 
second_Ses_Mean = zeros(25,10); 
secondIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{2,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
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curIndx(rows+1:rows+numLines,:) = 0; 
end 
 
second_Ses_Mean = second_Ses_Mean+curPatient; 
secondIndices = secondIndices + curIndx; 
end 
XX_02 = repmat(secondIndices,1,size(second_Ses_Mean,2)); 
second_Ses_Mean = second_Ses_Mean./XX_02 ; 
xlswrite([OutDir '\second_Ses_Mean.xls'],second_Ses_Mean) 
  
 % The Third Session 
%--------------------- 
third_Ses_Mean = zeros(25,10); 
thirdIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{3,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
third_Ses_Mean = third_Ses_Mean+curPatient; 
thirdIndices = thirdIndices + curIndx; 
end 
XX_03 = repmat(thirdIndices,1,size(third_Ses_Mean,2)); 
third_Ses_Mean = third_Ses_Mean./XX_03 ; 
xlswrite([OutDir '\third_Ses_Mean.xls'],third_Ses_Mean) 
 
% The Fourth Session 
%--------------------- 
fourth_Ses_Mean = zeros(25,10); 
fourthIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{4,cc}; 
[rows cols] = size(curPatient); 
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if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
fourth_Ses_Mean = fourth_Ses_Mean+curPatient; 
fourthIndices = fourthIndices + curIndx; 
end 
XX_04 = repmat(fourthIndices,1,size(fourth_Ses_Mean,2)); 
fourth_Ses_Mean = fourth_Ses_Mean./XX_04 ; 
xlswrite([OutDir '\fourth_Ses_Mean.xls'],fourth_Ses_Mean) 
 
% The Fifth Session 
%--------------------- 
fifth_Ses_Mean = zeros(25,10); 
fifthIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{5,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
fifth_Ses_Mean = fifth_Ses_Mean+curPatient; 
fifthIndices = fifthIndices + curIndx; 
end 
XX_05 = repmat(fifthIndices,1,size(fifth_Ses_Mean,2)); 
fifth_Ses_Mean = fifth_Ses_Mean./XX_05 ; 
xlswrite([OutDir '\fifth_Ses_Mean.xls'],fifth_Ses_Mean) 
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% The Sixth Session 
%--------------------- 
sixth_Ses_Mean = zeros(25,10); 
sixthIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{6,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
sixth_Ses_Mean = sixth_Ses_Mean+curPatient; 
sixthIndices = sixthIndices + curIndx; 
end 
XX_06 = repmat(sixthIndices,1,size(sixth_Ses_Mean,2)); 
sixth_Ses_Mean = sixth_Ses_Mean./XX_06 ; 
xlswrite([OutDir '\sixth_Ses_Mean.xls'],sixth_Ses_Mean) 
 
% The Seventh Session 
%--------------------- 
seventh_Ses_Mean = zeros(25,10); 
seventhIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{7,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
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curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
seventh_Ses_Mean = seventh_Ses_Mean+curPatient; 
seventhIndices = seventhIndices + curIndx; 
end 
XX_07 = repmat(seventhIndices,1,size(seventh_Ses_Mean,2)); 
seventh_Ses_Mean = seventh_Ses_Mean./XX_07 ; 
xlswrite([OutDir '\seventh_Ses_Mean.xls'],seventh_Ses_Mean) 
 
% The Eighth Session 
%--------------------- 
eighth_Ses_Mean = zeros(25,10); 
eighthIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{8,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
eighth_Ses_Mean = eighth_Ses_Mean+curPatient; 
eighthIndices = eighthIndices + curIndx; 
end 
XX_08 = repmat(eighthIndices,1,size(eighth_Ses_Mean,2)); 
eighth_Ses_Mean = eighth_Ses_Mean./XX_08 ; 
xlswrite([OutDir '\eighth_Ses_Mean.xls'],eighth_Ses_Mean) 
 
% The Ninth Session 
%--------------------- 
ninth_Ses_Mean = zeros(25,10); 
ninthIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{9,cc}; 
[rows cols] = size(curPatient); 
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if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
ninth_Ses_Mean = ninth_Ses_Mean+curPatient; 
ninthIndices = ninthIndices + curIndx; 
end 
 XX_09 = repmat(ninthIndices,1,size(ninth_Ses_Mean,2)); 
ninth_Ses_Mean = ninth_Ses_Mean./XX_09 ; 
xlswrite([OutDir '\ninth_Ses_Mean.xls'],ninth_Ses_Mean) 
 
% The Tenth Session 
%--------------------- 
tenth_Ses_Mean = zeros(25,10); 
tenthIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{10,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
tenth_Ses_Mean = tenth_Ses_Mean+curPatient; 
tenthIndices = tenthIndices + curIndx; 
end 
XX_10 = repmat(tenthIndices,1,size(tenth_Ses_Mean,2)); 
tenth_Ses_Mean = tenth_Ses_Mean./XX_10 ; 
xlswrite([OutDir '\tenth_Ses_Mean.xls'],tenth_Ses_Mean) 
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% The Eleventh Session 
%--------------------- 
eleventh_Ses_Mean = zeros(25,10); 
eleventhIndices = zeros(25,1); 
  
for cc = 1 : Ks 
curPatient = allSelected_Sessions{11,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
if rows<25 
numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
eleventh_Ses_Mean = eleventh_Ses_Mean+curPatient; 
eleventhIndices = eleventhIndices + curIndx; 
end 
XX_11 = repmat(eleventhIndices,1,size(eleventh_Ses_Mean,2)); 
eleventh_Ses_Mean = eleventh_Ses_Mean./XX_11 ; 
xlswrite([OutDir '\eleventh_Ses_Mean.xls'],eleventh_Ses_Mean) 
 
 
 
% The Twelfth Session 
%--------------------- 
twelfth_Ses_Mean = zeros(25,10); 
twelveIndices = zeros(25,1); 
 
for cc = 1 : Ks 
curPatient = allSelected_Sessions{12,cc}; 
[rows cols] = size(curPatient); 
if rows>=26 
curPatient(26:end,:) =[]; 
elseif rows<26 
curPatient(end,:) =[]; 
end 
curIndx = ones(25,1); 
[rows cols] = size(curPatient); 
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 if rows<25 
  numLines= 25-rows; 
curPatient(rows+1:rows+numLines,:) = 0; 
curIndx(rows+1:rows+numLines,:) = 0; 
end 
twelfth_Ses_Mean = twelfth_Ses_Mean+curPatient; 
twelveIndices = twelveIndices + curIndx; 
end 
XX_12 = repmat(twelveIndices,1,size(twelfth_Ses_Mean,2)); 
 twelfth_Ses_Mean = twelfth_Ses_Mean./XX_12 ; 
 xlswrite([OutDir '\twelfth_Ses_Mean.xls'],twelfth_Ses_Mean) 
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APPENDIX II: DATA TABLES 
 
 
 
A. Raw Data for Analysis 
 
TABLE VI 
 
RAW DATA FOR SESSION 1 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ 
Low Beta 
Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ 
Beta Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.145 0.084 0.027 0.013 0.027 0.026 7.306 4.501 2.73 3.323 71.501 38.594 
2 0.15 0.082 0.024 0.012 0.029 0.027 7.655 4.846 2.858 3.676 72.178 38.133 
3 0.138 0.079 0.023 0.012 0.025 0.027 7.682 4.672 2.809 3.733 72.58 38.2 
4 0.137 0.084 0.026 0.013 0.029 0.033 7.407 4.576 2.739 3.552 72.196 38.913 
5 0.141 0.087 0.031 0.015 0.032 0.031 7.807 4.701 2.86 3.44 72.603 39.189 
6 0.135 0.078 0.024 0.012 0.03 0.04 7.405 4.025 2.545 3.42 72.286 38.884 
7 0.136 0.084 0.027 0.014 0.036 0.047 7.418 4.23 2.617 3.491 71.214 38.864 
8 0.133 0.081 0.026 0.014 0.035 0.046 7.058 3.96 2.473 3.459 71.838 38.243 
9 0.143 0.085 0.023 0.014 0.036 0.047 8.504 4.83 3 3.903 72.352 38.541 
10 0.141 0.08 0.023 0.012 0.027 0.031 7.925 4.375 2.761 3.778 71.956 38.364 
11 0.137 0.091 0.026 0.013 0.03 0.032 8.169 4.81 2.92 3.843 71.789 37.127 
12 0.125 0.075 0.027 0.016 0.039 0.045 5.931 3.376 2.095 2.95 73.068 38.462 
13 0.14 0.082 0.026 0.015 0.032 0.035 7.06 3.87 2.435 3.46 72.64 38.115 
14 0.142 0.084 0.028 0.017 0.032 0.033 6.622 3.972 2.439 3.339 73.527 38.376 
15 0.134 0.081 0.026 0.015 0.037 0.041 6.895 4.486 2.634 3.634 72.438 38.631 
16 0.139 0.09 0.029 0.017 0.042 0.043 6.724 3.932 2.417 3.316 72.763 39.227 
17 0.138 0.08 0.02 0.011 0.029 0.033 8.682 4.645 2.943 4.068 72.414 37.487 
18 0.142 0.08 0.023 0.013 0.033 0.035 7.721 4.434 2.744 3.669 73.895 38.324 
19 0.142 0.081 0.023 0.015 0.037 0.039 7.908 4.476 2.761 3.793 73.846 40.133 
20 0.136 0.074 0.022 0.014 0.033 0.036 7.489 3.576 2.326 3.616 72.337 39.841 
21 0.135 0.082 0.025 0.016 0.045 0.057 6.394 3.326 2.114 3.565 68.69 40.593 
22 0.136 0.082 0.029 0.016 0.047 0.061 6.071 3.377 2.077 3.017 74.133 40.317 
23 0.126 0.079 0.024 0.014 0.043 0.053 7.044 3.561 2.285 3.281 73.867 40.64 
24 0.125 0.076 0.026 0.016 0.051 0.063 6.806 3.454 2.241 3.203 73.799 39.199 
25 0.144 0.087 0.03 0.016 0.044 0.047 9.698 6.307 3.704 4.02 73.28 37.095 
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TABLE VII 
 
RAW DATA FOR SESSION 2 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ Low 
Beta Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.142 0.081 0.022 0.011 0.026 0.03 8.449 5.57 3.279 3.93 73.338 37.982 
2 0.146 0.084 0.025 0.013 0.031 0.039 8.2 5.461 3.191 3.864 72.687 39.025 
3 0.145 0.076 0.022 0.011 0.023 0.026 8.049 4.71 2.928 3.811 75.021 38.235 
4 0.149 0.083 0.029 0.016 0.042 0.047 7.607 4.26 2.677 3.412 75.681 40.102 
5 0.138 0.079 0.025 0.013 0.03 0.028 7.464 4.287 2.663 3.336 75.598 38.192 
6 0.158 0.082 0.028 0.015 0.037 0.043 6.57 3.675 2.268 3.199 74.726 38.942 
7 0.139 0.079 0.027 0.015 0.041 0.045 6.339 3.504 2.166 3.341 73.283 39.594 
8 0.154 0.084 0.025 0.014 0.033 0.038 7.861 4.618 2.808 3.825 74.421 39.404 
9 0.146 0.082 0.027 0.015 0.041 0.046 6.97 3.617 2.306 3.32 73.367 39.614 
10 0.157 0.101 0.033 0.021 0.056 0.071 6.428 3.762 2.282 3.32 71.871 38.956 
11 0.157 0.095 0.032 0.019 0.053 0.064 7.306 5.044 2.816 3.561 72.961 39.804 
12 0.145 0.08 0.027 0.016 0.04 0.044 6.104 3.627 2.225 3.24 74.146 39.329 
13 0.142 0.083 0.027 0.017 0.042 0.057 6.076 3.429 2.135 3.268 73.025 40.039 
14 0.144 0.085 0.026 0.016 0.047 0.053 6.931 3.591 2.302 3.583 73.708 40.203 
15 0.14 0.081 0.026 0.017 0.049 0.059 6.86 3.53 2.275 3.303 73.416 40.315 
16 0.138 0.082 0.027 0.016 0.046 0.067 6.273 3.496 2.197 3.225 73.629 39.284 
17 0.141 0.083 0.028 0.018 0.043 0.058 6.004 3.373 2.098 3.202 74.729 39.347 
18 0.135 0.078 0.025 0.014 0.031 0.038 6.753 4.139 2.507 3.353 74.914 38.782 
19 0.137 0.08 0.027 0.016 0.04 0.05 7.194 4.309 2.644 3.509 73.477 38.667 
20 0.142 0.079 0.024 0.013 0.03 0.037 8.297 5.062 3.084 3.871 73.793 38.146 
21 0.146 0.087 0.027 0.015 0.04 0.043 7.16 4.258 2.618 3.538 74.263 38.38 
22 0.146 0.082 0.028 0.017 0.042 0.051 6.846 3.964 2.452 3.211 75.356 38.04 
23 0.152 0.084 0.028 0.016 0.04 0.046 7.251 4.334 2.644 3.555 73.652 37.042 
24 0.141 0.089 0.031 0.018 0.046 0.051 6.887 4.318 2.559 3.23 75.513 36.348 
25 0.14 0.086 0.029 0.015 0.035 0.041 7.207 4.197 2.574 3.311 74.453 36.102 
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TABLE VIII 
 
RAW DATA FOR SESSION 3 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low 
Beta 
Relative 
Power 
High 
Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ 
Low 
Beta 
Ratio 
Theta/ 
High 
Beta 
Ratio 
Theta/ 
Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.148 0.091 0.024 0.011 0.021 0.022 8.579 6.309 3.514 4.094 73.712 34.095 
2 0.136 0.083 0.025 0.013 0.027 0.029 7.537 4.473 2.72 3.544 74.791 36.5 
3 0.138 0.094 0.029 0.014 0.028 0.026 7.642 4.485 2.731 3.502 74.849 37.909 
4 0.141 0.083 0.026 0.013 0.031 0.032 7.138 3.763 2.371 3.64 74.001 39.879 
5 0.13 0.081 0.027 0.014 0.035 0.03 7.108 3.626 2.335 3.607 73.367 39.215 
6 0.138 0.085 0.028 0.015 0.035 0.03 7.363 3.829 2.447 3.786 74.221 39.265 
7 0.138 0.085 0.028 0.016 0.042 0.036 6.453 3.312 2.131 3.481 74.997 39.98 
8 0.136 0.075 0.026 0.013 0.032 0.031 6.895 3.393 2.199 3.454 73.072 38.831 
9 0.132 0.079 0.027 0.014 0.033 0.026 6.523 3.457 2.185 3.458 76.504 36.843 
10 0.135 0.084 0.039 0.014 0.033 0.031 6.69 3.184 2.09 3.359 74.125 36.388 
11 0.137 0.085 0.028 0.013 0.03 0.04 7.297 3.972 2.45 3.401 72.526 37.482 
12 0.133 0.083 0.027 0.015 0.034 0.035 6.967 3.781 2.397 3.386 73.727 38.771 
13 0.136 0.082 0.035 0.017 0.046 0.071 6.919 3.848 2.409 3.158 73.604 38.985 
14 0.14 0.078 0.027 0.013 0.028 0.027 6.44 3.79 2.314 3.21 75.019 37.82 
15 0.132 0.081 0.028 0.015 0.029 0.024 6.97 4.172 2.559 3.308 75.497 37.498 
16 0.141 0.089 0.029 0.016 0.034 0.028 7.4 4.467 2.722 3.585 75.56 38.46 
17 0.134 0.083 0.036 0.016 0.04 0.033 7.381 4.34 2.651 3.33 74.934 37.648 
18 0.132 0.09 0.029 0.016 0.038 0.036 8.029 4.55 2.805 3.736 74.807 38.332 
19 0.146 0.1 0.032 0.017 0.038 0.039 9.059 5.339 3.31 3.984 75.077 39.12 
20 0.136 0.081 0.032 0.016 0.042 0.041 6.99 4.074 2.494 3.499 73.442 38.528 
21 0.131 0.086 0.032 0.018 0.043 0.048 6.408 4.247 2.457 3.133 75.173 38.69 
22 0.131 0.082 0.03 0.016 0.036 0.03 7.077 4.45 2.665 3.416 74.617 38.491 
23 0.127 0.087 0.03 0.015 0.03 0.03 6.855 3.978 2.44 3.403 74.636 38.872 
24 0.122 0.079 0.028 0.015 0.035 0.036 7.271 4.29 2.593 3.693 73.784 38.417 
25 0.133 0.087 0.028 0.014 0.031 0.029 7.781 4.737 2.843 3.847 75.727 38.108 
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TABLE IX 
 
RAW DATA FOR SESSION 4 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ Low 
Beta Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.132 0.084 0.026 0.013 0.027 0.028 7.675 5.348 3.091 3.322 71.642 35.893 
2 0.137 0.08 0.027 0.015 0.035 0.04 6.437 4.034 2.41 3.201 71.305 38.589 
3 0.141 0.078 0.026 0.013 0.03 0.035 7.077 4.399 2.63 3.326 73.45 38.523 
4 0.135 0.081 0.028 0.015 0.033 0.033 7.007 4.24 2.604 3.306 74.448 38.279 
5 0.132 0.082 0.029 0.016 0.037 0.035 6.789 4.198 2.554 3.165 75.154 39.355 
6 0.134 0.079 0.025 0.014 0.035 0.035 7.807 4.847 2.892 3.508 73.932 38.947 
7 0.136 0.08 0.027 0.015 0.038 0.035 7.85 4.992 2.992 3.491 74.597 39.313 
8 0.144 0.082 0.029 0.016 0.043 0.039 7.28 4.457 2.695 3.313 74.326 40.145 
9 0.132 0.081 0.028 0.014 0.04 0.044 6.762 3.512 2.252 3.076 74.468 39.863 
10 0.129 0.079 0.029 0.016 0.044 0.041 6.693 3.575 2.281 3.11 75.251 40.297 
11 0.132 0.079 0.026 0.015 0.035 0.032 6.387 3.429 2.193 3.187 74.58 39.94 
12 0.141 0.08 0.025 0.013 0.032 0.03 6.946 3.77 2.386 3.417 73.92 39.062 
13 0.14 0.077 0.028 0.015 0.044 0.042 6.838 3.614 2.302 3.092 73.962 39.108 
14 0.136 0.077 0.025 0.014 0.041 0.035 7.004 4.093 2.544 3.303 74.454 38.51 
15 0.133 0.078 0.027 0.015 0.054 0.087 6.753 3.932 2.422 3.033 72.996 39.488 
16 0.128 0.083 0.029 0.016 0.038 0.042 5.866 3.227 2.037 3.031 75.623 40.239 
17 0.132 0.088 0.029 0.016 0.042 0.039 6.38 3.899 2.358 3.193 75.26 38.83 
18 0.125 0.082 0.028 0.015 0.036 0.035 6.534 3.989 2.38 3.15 73.979 38.815 
19 0.132 0.081 0.028 0.015 0.033 0.041 6.4 3.676 2.277 2.985 75.626 37.926 
20 0.141 0.082 0.029 0.016 0.04 0.041 6.265 3.818 2.312 3.052 75.968 39.135 
21 0.143 0.092 0.03 0.016 0.036 0.046 7.211 4.28 2.616 3.442 75.196 37.58 
22 0.128 0.091 0.029 0.015 0.036 0.055 6.895 4.681 2.713 3.208 75.505 37.346 
23 0.129 0.079 0.028 0.014 0.034 0.045 6.311 4.036 2.407 2.97 76.38 35.761 
24 0.13 0.089 0.03 0.015 0.03 0.024 6.647 4.409 2.577 3.155 77.544 35.07 
25 0.138 0.075 0.024 0.012 0.026 0.023 7.291 4.615 2.733 3.212 75.154 37.609 
 
72 
 
TABLE X 
 
RAW DATA FOR SESSION 5 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ Low 
Beta Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.139 0.104 0.035 0.02 0.034 0.036 6.976 4.948 2.819 3.67 73.445 37.632 
2 0.146 0.088 0.031 0.018 0.035 0.036 6.869 4.567 2.693 3.194 74.314 37.077 
3 0.144 0.083 0.029 0.017 0.033 0.031 6.147 3.838 2.316 3.074 75.721 37.527 
4 0.138 0.092 0.036 0.02 0.047 0.056 6.23 3.629 2.228 2.942 75.974 38.003 
5 0.132 0.083 0.032 0.018 0.046 0.054 6.231 3.65 2.245 2.963 76.56 40.897 
6 0.133 0.08 0.031 0.016 0.036 0.034 6.399 3.414 2.17 3.01 76.234 39.863 
7 0.141 0.089 0.036 0.019 0.042 0.043 6.268 3.593 2.22 3.054 76.213 39.384 
8 0.129 0.083 0.031 0.017 0.038 0.036 6.011 3.329 2.102 2.976 76.488 39.943 
9 0.129 0.076 0.029 0.015 0.031 0.03 6.158 3.529 2.193 2.884 76.63 39.462 
10 0.142 0.085 0.03 0.015 0.039 0.049 7.098 4.022 2.513 3.161 74.935 38.993 
11 0.137 0.09 0.033 0.018 0.054 0.076 6.669 3.868 2.376 3.239 75.059 39.409 
12 0.14 0.073 0.024 0.014 0.038 0.042 7.507 4.537 2.779 3.463 75.371 39.727 
13 0.142 0.08 0.029 0.016 0.037 0.035 6.958 4.206 2.555 3.193 75.709 38.924 
14 0.13 0.081 0.028 0.016 0.041 0.052 7.309 4.531 2.74 3.108 75.13 38.699 
15 0.137 0.079 0.03 0.017 0.042 0.048 6.512 4.063 2.433 2.908 74.121 38.314 
16 0.137 0.086 0.028 0.016 0.042 0.046 7.25 4.631 2.759 3.311 75.551 38.842 
17 0.136 0.082 0.03 0.019 0.056 0.07 6.529 4.052 2.45 3.283 75.662 39.252 
18 0.149 0.086 0.027 0.016 0.042 0.058 7.167 4.377 2.663 3.545 74.708 38.977 
19 0.131 0.08 0.031 0.017 0.047 0.055 6.721 4.116 2.486 3.132 74.628 39.241 
20 0.139 0.083 0.029 0.015 0.04 0.05 7.188 4.683 2.761 3.224 74.307 39.331 
21 0.133 0.085 0.031 0.017 0.047 0.067 7.499 4.418 2.718 3.049 72.788 38.651 
22 0.141 0.086 0.03 0.016 0.046 0.046 7.66 4.534 2.788 3.213 74.279 39.8 
23 0.13 0.084 0.032 0.018 0.047 0.059 7.488 4.707 2.832 3.081 75.226 38.113 
24 0.135 0.085 0.036 0.02 0.052 0.056 6.697 3.789 2.377 3.134 75.032 38.533 
25 0.135 0.081 0.027 0.015 0.038 0.045 7.212 4.134 2.581 3.338 75.375 39.098 
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TABLE XI 
 
RAW DATA FOR SESSION 6 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ 
Low Beta 
Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ 
Beta Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.128 0.08 0.023 0.011 0.021 0.02 8.406 5.886 3.361 3.665 73.686 35.895 
2 0.133 0.081 0.022 0.01 0.019 0.019 8.858 5.455 3.282 3.931 73.381 35.593 
3 0.125 0.083 0.029 0.014 0.028 0.023 6.989 4.29 2.571 3.301 76.244 37.257 
4 0.133 0.09 0.05 0.027 0.061 0.053 6.787 3.988 2.439 3.258 77.404 36.773 
5 0.14 0.098 0.071 0.041 0.094 0.083 6.585 3.686 2.306 3.215 77.11 36.064 
6 0.137 0.098 0.067 0.04 0.096 0.086 6.74 3.597 2.282 3.265 77.008 36.609 
7 0.132 0.098 0.065 0.041 0.097 0.087 6.298 3.406 2.156 3.164 76.549 36.425 
8 0.143 0.107 0.083 0.047 0.109 0.093 6.583 3.647 2.296 2.97 77.073 35.959 
9 0.14 0.092 0.075 0.043 0.102 0.097 6.374 3.199 2.072 3.14 76.545 37.138 
10 0.134 0.097 0.066 0.039 0.091 0.083 6.628 3.534 2.25 3.116 76.33 37.193 
11 0.153 0.109 0.102 0.054 0.127 0.107 7.529 3.947 2.515 3.486 75.906 35.741 
12 0.134 0.087 0.029 0.014 0.031 0.026 7.547 4.451 2.695 3.511 76.827 36.59 
13 0.14 0.094 0.033 0.016 0.034 0.026 7.129 4.169 2.579 3.19 76.158 38.245 
14 0.125 0.078 0.028 0.015 0.035 0.034 6.619 3.714 2.313 3.204 76.541 39.349 
15 0.139 0.082 0.028 0.015 0.033 0.031 6.691 3.729 2.346 3.292 76.222 38.987 
16 0.126 0.08 0.03 0.016 0.034 0.028 6.453 3.779 2.335 2.983 76.532 39.245 
17 0.13 0.08 0.027 0.015 0.031 0.026 6.813 3.771 2.392 3.185 75.117 37.639 
18 0.142 0.084 0.027 0.015 0.029 0.025 7.708 4.489 2.814 3.418 75.282 37.044 
19 0.136 0.089 0.032 0.017 0.039 0.038 6.933 3.936 2.459 3.148 75.362 38.658 
20 0.129 0.09 0.034 0.018 0.045 0.045 6.701 3.919 2.401 3.238 75.35 38.478 
21 0.126 0.078 0.028 0.016 0.035 0.035 6.93 3.879 2.443 3.224 75.722 38.551 
22 0.13 0.082 0.031 0.017 0.04 0.04 6.12 3.797 2.294 2.931 76.739 39.297 
23 0.136 0.094 0.033 0.018 0.044 0.044 6.76 4.111 2.498 3.217 75.972 38.48 
24 0.127 0.091 0.03 0.017 0.043 0.043 6.883 4.085 2.497 3.294 75.778 39.364 
25 0.134 0.084 0.029 0.016 0.036 0.036 6.545 3.827 2.366 3.292 74.213 37.304 
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TABLE XII 
 
RAW DATA FOR SESSION 7 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ 
Low Beta 
Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ 
Beta Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.139 0.079 0.028 0.013 0.024 0.022 7.126 4.947 2.873 3.098 72.748 36.313 
2 0.14 0.088 0.025 0.013 0.025 0.024 7.751 5.219 3.067 3.64 73.173 36.783 
3 0.138 0.08 0.027 0.014 0.027 0.025 6.461 4.086 2.434 3.09 74.488 37.943 
4 0.126 0.087 0.033 0.016 0.037 0.038 6.777 3.943 2.437 2.99 74.597 38.22 
5 0.138 0.08 0.026 0.014 0.029 0.029 7.011 4.215 2.58 3.232 74.746 39.239 
6 0.146 0.088 0.031 0.016 0.032 0.036 6.368 3.845 2.316 3.053 74.429 39.284 
7 0.141 0.083 0.029 0.015 0.031 0.032 7.037 4.391 2.638 3.282 74.458 39.486 
8 0.139 0.09 0.04 0.021 0.043 0.044 6.916 3.784 2.369 2.942 74.384 39.947 
9 0.136 0.089 0.034 0.019 0.044 0.05 6.072 3.505 2.124 2.997 74.853 40.275 
10 0.14 0.094 0.035 0.02 0.048 0.05 5.756 3.462 2.079 3.035 74.602 40.1 
11 0.137 0.079 0.033 0.017 0.042 0.042 6.337 3.681 2.262 2.776 74.897 40.422 
12 0.138 0.09 0.044 0.022 0.052 0.055 6.568 3.819 2.355 2.927 74.354 39.321 
13 0.135 0.081 0.035 0.017 0.035 0.031 6.817 4.116 2.487 2.937 74.769 38.788 
14 0.135 0.09 0.039 0.021 0.049 0.051 6.419 3.563 2.238 2.886 75.575 40.341 
15 0.13 0.086 0.036 0.019 0.045 0.044 6.817 3.77 2.373 3.036 74.947 40.026 
16 0.133 0.078 0.03 0.016 0.031 0.03 7.078 4.009 2.503 3.142 75.477 40.025 
17 0.138 0.091 0.039 0.02 0.045 0.041 6.869 3.829 2.43 2.924 75.733 39.954 
18 0.141 0.084 0.032 0.019 0.038 0.041 6.67 4.105 2.496 3.098 75.097 40.532 
19 0.136 0.084 0.031 0.016 0.033 0.03 7.343 4.141 2.614 3.266 75.021 37.839 
20 0.156 0.086 0.033 0.018 0.033 0.026 6.801 4.3 2.604 2.935 75.665 36.801 
21 0.141 0.091 0.035 0.018 0.031 0.026 7.163 4.591 2.757 3.09 74.755 38.404 
22 0.153 0.088 0.029 0.015 0.026 0.023 7.645 5.529 3.142 3.335 74.479 38.932 
23 0.138 0.079 0.029 0.017 0.029 0.026 6.955 4.515 2.702 3.033 74.532 38.434 
24 0.142 0.084 0.033 0.018 0.031 0.03 6.751 4.378 2.593 3.038 75.1 38.911 
25 0.13 0.088 0.035 0.019 0.033 0.03 6.662 4.456 2.606 2.928 74.549 38.54 
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TABLE XIII 
 
RAW DATA FOR SESSION 8 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ Low 
Beta Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.135 0.101 0.028 0.013 0.019 0.017 8.448 6.36 3.545 3.7 74.524 35.839 
2 0.136 0.071 0.022 0.011 0.019 0.018 7.118 4.421 2.691 3.377 74.264 36.606 
3 0.13 0.075 0.026 0.012 0.027 0.024 6.817 3.733 2.362 3.158 76.237 38.611 
4 0.143 0.073 0.024 0.011 0.023 0.02 7.379 4.28 2.642 3.195 75.235 38.588 
5 0.139 0.086 0.028 0.014 0.033 0.03 7.078 4.039 2.473 3.298 75.949 38.345 
6 0.142 0.078 0.025 0.013 0.028 0.026 7.078 3.97 2.422 3.435 76.118 38.102 
7 0.135 0.081 0.028 0.014 0.033 0.028 6.354 3.568 2.197 3.122 76.369 39.232 
8 0.134 0.073 0.025 0.012 0.03 0.028 6.796 3.556 2.255 3.188 75.015 40.697 
9 0.136 0.087 0.028 0.015 0.039 0.04 7.089 3.487 2.253 3.582 74.378 41.524 
10 0.14 0.081 0.026 0.013 0.036 0.032 7.159 3.39 2.226 3.43 74.63 40.809 
11 0.14 0.07 0.021 0.011 0.028 0.025 7.025 3.24 2.147 3.495 74.365 40.434 
12 0.148 0.076 0.024 0.012 0.031 0.026 6.804 3.716 2.281 3.318 74.625 39.972 
13 0.139 0.073 0.022 0.011 0.026 0.025 7.096 3.562 2.3 3.467 74.143 40.606 
14 0.143 0.083 0.028 0.014 0.033 0.027 6.948 3.737 2.349 3.333 74.987 40.206 
15 0.138 0.084 0.031 0.016 0.035 0.028 6.066 3.208 2.05 3 76.677 39.033 
16 0.139 0.086 0.03 0.013 0.027 0.022 7.472 4.658 2.794 3.149 75.181 38.515 
17 0.128 0.082 0.029 0.015 0.03 0.028 6.926 3.922 2.441 3.087 75.92 39.034 
18 0.134 0.079 0.027 0.013 0.031 0.028 6.698 3.146 2.097 3.221 75.471 39.191 
19 0.138 0.077 0.026 0.013 0.029 0.023 6.475 3.299 2.136 3.106 75.769 39.031 
20 0.138 0.08 0.031 0.018 0.038 0.034 5.887 3.338 2.074 3.036 76.002 39.597 
21 0.131 0.076 0.029 0.016 0.038 0.031 5.932 3.463 2.117 2.996 76.554 41.447 
22 0.139 0.073 0.028 0.015 0.032 0.027 6.441 3.412 2.193 3.231 76.011 38.774 
23 0.135 0.073 0.026 0.014 0.032 0.028 5.741 2.956 1.919 3.073 74.782 40.507 
24 0.146 0.079 0.025 0.013 0.03 0.03 6.864 3.626 2.314 3.427 76.025 41.262 
25 0.147 0.076 0.028 0.014 0.033 0.032 7.019 4.561 2.676 3.221 75.415 40.442 
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TABLE XIV 
 
RAW DATA FOR SESSION 9 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ 
Low Beta 
Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ 
Beta Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.15 0.092 0.03 0.013 0.025 0.024 7.586 4.712 2.854 3.345 73.691 36.066 
2 0.149 0.093 0.034 0.019 0.034 0.033 6.18 3.952 2.337 3.169 73.835 37.678 
3 0.145 0.091 0.032 0.017 0.03 0.029 6.027 3.563 2.164 3.186 75.605 37.669 
4 0.145 0.091 0.033 0.017 0.031 0.029 6.121 3.666 2.221 3.156 74.44 38.222 
5 0.135 0.101 0.041 0.021 0.043 0.039 5.595 3.239 1.992 2.896 74.53 38.177 
6 0.132 0.098 0.043 0.022 0.04 0.035 5.377 3.203 1.959 2.68 74.972 37.909 
7 0.133 0.096 0.04 0.02 0.035 0.034 5.557 3.202 1.992 2.804 75.475 38.897 
8 0.134 0.1 0.042 0.023 0.045 0.051 5.632 3.203 1.989 3.01 74.718 38.917 
9 0.13 0.085 0.032 0.018 0.042 0.04 5.901 3.267 2.068 2.973 75.289 38.38 
10 0.138 0.084 0.028 0.015 0.038 0.036 6.333 3.28 2.12 3.228 74.886 38.929 
11 0.124 0.082 0.033 0.02 0.043 0.039 5.41 2.805 1.816 2.752 75.933 39.897 
12 0.132 0.084 0.033 0.02 0.041 0.035 5.526 3.158 1.97 2.796 75.639 39.531 
13 0.133 0.089 0.034 0.021 0.046 0.043 5.527 3.008 1.898 2.858 75.41 39.187 
14 0.134 0.087 0.032 0.019 0.042 0.041 5.866 3.462 2.114 3.011 75.612 38.895 
15 0.127 0.081 0.029 0.018 0.039 0.039 5.388 2.919 1.856 2.969 76.096 39.199 
16 0.143 0.083 0.03 0.019 0.048 0.049 6.196 3.377 2.127 3.154 75.796 39.286 
17 0.133 0.086 0.035 0.019 0.047 0.042 5.926 3.301 2.039 3.045 75.801 38.165 
18 0.129 0.071 0.026 0.015 0.031 0.028 6.122 3.22 2.058 3.074 76.309 37.985 
19 0.126 0.078 0.032 0.019 0.041 0.036 5.748 3.05 1.95 2.87 76.242 38.135 
20 0.131 0.078 0.034 0.017 0.033 0.028 5.98 3.246 2.079 2.874 76.121 37.865 
21 0.137 0.099 0.032 0.017 0.033 0.028 7.288 4.635 2.779 3.358 75.939 38.393 
22 0.131 0.081 0.033 0.017 0.037 0.032 5.946 3.228 2.061 2.839 77.192 38.635 
23 0.136 0.084 0.034 0.02 0.05 0.05 6.103 3.314 2.108 2.975 76.434 38.973 
24 0.129 0.084 0.032 0.02 0.047 0.047 5.926 3.247 2.061 3.08 74.686 38.132 
25 0.136 0.08 0.031 0.018 0.044 0.04 6.085 3.059 2.011 3.04 75.696 38.676 
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TABLE XV 
 
RAW DATA FOR SESSION 10 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ Low 
Beta Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.137 0.088 0.029 0.014 0.024 0.028 7.46 5.052 2.936 3.33 74.341 34.761 
2 0.133 0.078 0.035 0.012 0.022 0.024 7.186 4.601 2.778 3.068 73.64 36.375 
3 0.128 0.092 0.034 0.017 0.038 0.035 6.622 3.964 2.419 3.062 75.155 37.737 
4 0.128 0.085 0.032 0.016 0.036 0.033 6.189 3.627 2.238 3.05 75.42 38.159 
5 0.12 0.081 0.028 0.015 0.031 0.032 6.086 3.413 2.158 2.956 75.031 37.754 
6 0.14 0.095 0.033 0.017 0.031 0.028 6.52 3.896 2.382 3.057 74.71 37.738 
7 0.138 0.088 0.034 0.016 0.032 0.028 6.066 3.67 2.222 3.052 75.427 38.281 
8 0.122 0.076 0.028 0.014 0.032 0.034 6.094 3.009 1.982 2.993 74.714 38.244 
9 0.131 0.083 0.029 0.015 0.03 0.03 6.325 3.539 2.204 3.065 74.831 37.76 
10 0.139 0.09 0.03 0.015 0.029 0.027 6.557 4.068 2.426 3.136 75.565 38.257 
11 0.13 0.086 0.03 0.015 0.032 0.029 6.288 3.804 2.287 3.205 75.937 38.762 
12 0.131 0.088 0.033 0.017 0.038 0.038 6.114 3.353 2.104 2.952 75.24 38.007 
13 0.133 0.086 0.029 0.015 0.031 0.028 6.567 4.075 2.43 3.22 74.864 37.519 
14 0.128 0.083 0.032 0.015 0.032 0.035 6.762 4.116 2.503 2.999 75.226 37.231 
15 0.133 0.081 0.03 0.015 0.031 0.028 6.253 3.551 2.188 2.948 74.854 38.923 
16 0.129 0.087 0.035 0.018 0.039 0.036 6.042 3.601 2.189 2.874 76.314 39.037 
17 0.124 0.087 0.031 0.016 0.034 0.031 6.339 3.889 2.355 2.986 75.691 38.261 
18 0.131 0.085 0.026 0.014 0.027 0.022 7.431 4.601 2.744 3.434 75.737 37.944 
19 0.127 0.089 0.032 0.017 0.035 0.034 6.348 4.054 2.425 3.02 75.267 38.763 
20 0.146 0.101 0.085 0.049 0.112 0.097 6.056 3.541 2.182 2.928 75.586 38.693 
21 0.137 0.096 0.071 0.042 0.094 0.085 6.32 3.882 2.346 3.158 76.042 37.917 
22 0.146 0.103 0.095 0.053 0.12 0.101 6.627 4.141 2.509 3.107 74.892 36.537 
23 0.131 0.077 0.028 0.014 0.028 0.025 6.607 4.092 2.434 2.983 74.993 37.768 
24 0.132 0.085 0.028 0.015 0.03 0.029 6.69 3.693 2.352 3.15 75.435 37.654 
25 0.123 0.072 0.026 0.014 0.029 0.025 6.783 3.877 2.4 3.228 74.483 37.552 
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TABLE XVI 
 
RAW DATA FOR SESSION 11 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ Low 
Beta Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.164 0.089 0.031 0.015 0.027 0.022 6.803 4.66 2.698 3.141 74.025 34.773 
2 0.14 0.081 0.026 0.014 0.031 0.031 7.446 4.822 2.84 3.502 73.925 37.519 
3 0.136 0.075 0.026 0.013 0.031 0.029 6.67 3.921 2.394 3.299 74.799 39.197 
4 0.157 0.083 0.027 0.014 0.03 0.028 7.358 4.037 2.542 3.509 74.649 39.11 
5 0.148 0.086 0.026 0.014 0.029 0.028 7.179 4.094 2.51 3.38 74.358 38.859 
6 0.142 0.078 0.025 0.013 0.03 0.026 6.841 3.496 2.26 3.424 75.455 39.009 
7 0.132 0.085 0.026 0.014 0.036 0.033 6.938 3.247 2.134 3.543 73.967 38.914 
8 0.143 0.08 0.025 0.014 0.037 0.034 6.68 3.26 2.092 3.587 75.452 38.707 
9 0.141 0.079 0.022 0.011 0.025 0.025 7.711 4.102 2.623 3.814 75.727 36.127 
10 0.141 0.077 0.022 0.011 0.024 0.025 7.618 4.037 2.572 3.652 76.038 36.539 
11 0.137 0.072 0.022 0.012 0.03 0.034 7.546 3.874 2.519 3.715 76.735 36.883 
12 0.137 0.072 0.023 0.012 0.029 0.031 7.396 3.345 2.252 3.466 76.695 37.787 
13 0.136 0.077 0.025 0.014 0.035 0.037 7.053 3.268 2.195 3.443 76.798 37.696 
14 0.134 0.073 0.025 0.013 0.031 0.033 6.838 3.518 2.284 3.425 77.363 36.802 
15 0.132 0.073 0.026 0.014 0.033 0.033 6.61 3.805 2.374 3.286 78.498 37.545 
16 0.129 0.073 0.026 0.014 0.034 0.035 6.292 3.354 2.147 3.178 77.522 37.317 
17 0.135 0.076 0.027 0.014 0.036 0.038 6.081 3.318 2.07 2.954 75.218 38.298 
18 0.136 0.078 0.027 0.016 0.035 0.04 5.668 3.235 2.001 3.076 75.253 38.338 
19 0.141 0.084 0.031 0.018 0.041 0.041 5.838 3.22 2.028 3.059 76.636 39.676 
20 0.14 0.078 0.025 0.014 0.034 0.045 7.626 4.653 2.833 3.493 74.279 37.926 
21 0.14 0.076 0.027 0.017 0.032 0.029 5.47 2.845 1.831 3.077 73.256 39.237 
22 0.142 0.072 0.028 0.014 0.029 0.029 5.872 3.304 2.052 2.897 76.213 36.81 
23 0.137 0.071 0.023 0.012 0.026 0.025 6.194 3.171 2.077 3.347 75.702 36.689 
24 0.134 0.073 0.026 0.014 0.03 0.033 5.532 3.214 1.976 2.932 75.832 40.381 
25 0.128 0.073 0.025 0.014 0.032 0.032 5.707 2.899 1.893 3.046 75.309 39.848 
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TABLE XVII 
 
RAW DATA FOR SESSION 12 
Minute 
Delta 
Relative 
Power 
Theta 
Relative 
Power 
Alpha 
Relative 
Power 
Low Beta 
Relative 
Power 
High Beta 
Relative 
Power 
Gamma 
Relative 
Power 
Theta/ Low 
Beta Ratio 
Theta/ 
High Beta 
Ratio 
Theta/ Beta 
Ratio 
Theta/ 
Alpha 
Ratio 
"Focus" "Alertness" 
1 0.139 0.094 0.032 0.013 0.022 0.02 7.946 5.649 3.198 3.163 73.05 35.957 
2 0.141 0.078 0.026 0.012 0.025 0.025 7.371 5.349 3.033 3.225 73.601 37.421 
3 0.127 0.076 0.031 0.016 0.038 0.04 6.745 3.96 2.446 2.856 75.182 38.424 
4 0.135 0.08 0.029 0.015 0.042 0.043 7.623 4.305 2.675 3.265 74.866 38.131 
5 0.13 0.077 0.03 0.016 0.047 0.041 6.472 3.44 2.189 2.999 76.354 38.984 
6 0.125 0.073 0.028 0.016 0.046 0.044 6.693 3.928 2.41 3.186 76.394 37.611 
7 0.133 0.081 0.029 0.015 0.041 0.038 10.4 6.774 4.022 3.564 76.236 37.986 
8 0.139 0.082 0.025 0.013 0.035 0.03 7.743 4.099 2.616 3.549 76.331 37.577 
9 0.129 0.076 0.029 0.016 0.042 0.036 6.692 3.426 2.208 3.024 77.845 35.372 
10 0.132 0.073 0.029 0.015 0.041 0.034 6.727 4.166 2.467 3.129 77.134 36.59 
11 0.131 0.091 0.034 0.016 0.038 0.035 7.694 4.46 2.726 3.143 78.148 36.715 
12 0.128 0.087 0.043 0.031 0.08 0.093 6.309 3.488 2.167 3.086 77.634 37.735 
13 0.148 0.093 0.046 0.031 0.076 0.078 6.972 4.833 2.672 3.454 76.471 36.781 
14 0.155 0.105 0.069 0.04 0.096 0.093 7.679 5.611 3.076 3.333 77.645 35.519 
15 0.14 0.103 0.073 0.042 0.099 0.091 6.38 4.256 2.446 2.972 77.604 35.658 
16 0.14 0.101 0.078 0.045 0.106 0.093 6.632 4.04 2.416 3.045 77.622 35.468 
17 0.125 0.083 0.03 0.017 0.037 0.033 6.506 3.864 2.312 3.109 76.593 37.175 
18 0.133 0.08 0.029 0.018 0.04 0.041 5.923 3.231 2.009 3.021 75.893 38.992 
19 0.132 0.082 0.03 0.016 0.038 0.038 6.307 3.143 2.046 3.071 76.47 36.614 
20 0.129 0.084 0.028 0.015 0.031 0.028 6.941 4.228 2.525 3.201 76.996 35.567 
21 0.133 0.082 0.034 0.018 0.037 0.029 5.93 3.938 2.254 2.785 77.621 36.189 
22 0.118 0.09 0.037 0.019 0.045 0.042 6.499 4.003 2.332 2.921 76.569 35.314 
23 0.116 0.081 0.031 0.017 0.041 0.035 6.039 3.736 2.202 2.914 77.594 36.076 
24 0.127 0.095 0.035 0.019 0.041 0.036 7.005 4.408 2.591 3.418 76.396 37.127 
25 0.119 0.088 0.04 0.019 0.041 0.036 6.375 4.188 2.407 2.837 75.538 37.68 
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B. T-test Results for ABC and IVA+Plus Measures 
 
 
 
 
TABLE XVIII 
 
SUMMARY OF ABC T-TEST 
 
Paired 
Measure 
Paired Differences 
df Mean 
Standard 
Deviation 
Standard 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
t-
statistic 
p-value 
Lower Upper 
Irritability 17 3.330 3.926 0.925 1.381 5.286 3.602 0.002 
Lethargy 17 4.056 7.272 1.714 0.439 7.672 2.366 0.030 
Stereotypy 17 1.333 2.249 0.530 0.215 2.452 2.515 0.022 
Hyperactivity 17 4.444 5.913 1.394 1.504 7.385 3.189 0.005 
Inappropriate 
Speech 
17 1.000 0.907 0.214 0.549 1.451 4.675 0.000 
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TABLE XIX 
 
SUMMARY OF IVA+PLUS T-TEST 
 
Paired 
Measure 
Paired Differences 
df Mean 
Standard 
Deviation 
Standard 
Error 
Mean 
95% Confidence 
Interval of the 
Difference t-statistic p-value 
Lower Upper 
Response 
Control 
Quotient 
17 -2.5 25.025 5.899 -14.945 9.945 -0.424 0.677 
Response 
Control 
Quotient 
Auditory 
17 -5.788 22.972 5.415 -17.201 5.646 -1.067 0.301 
Response 
Control 
Quotient 
Visual 
17 1.444 24.181 5.7 -10.581 13.469 0.253 0.803 
Attention 
Quotient 
17 -9.222 15.187 3.58 -16.775 -1.67 -2.576 0.02* 
Attention 
Quotient 
Auditory 
17 -8.667 18.279 4.308 -17.757 0.423 -2.012 0.06 
Attention 
Quotient 
Visual 
17 -8 14.852 3.501 -15.386 -0.614 -2.285 0.035* 
Sustained 
Auditory 
Attention 
Quotient 
17 -13.278 28.042 6.609 -27.223 0.667 -2.009 0.061 
Sustained 
Visual 
Attention 
Quotient 
17 -14.389 22.432 5.287 -25.544 -3.234 -2.721 0.015* 
Auditory 
Reaction 
Time 
17 36.556 85.614 20.179 -6.019 79.13 1.812 0.088* 
Visual 
Reaction 
Time 
17 21.833 38.938 9.178 2.47 41.197 2.379 0.029* 
*indicates p<0.05 
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C.  MiniTab ANOVA Output and Pearson Correlation Test Output 
 
 
ANOVA Output 
 
Analysis of Variance for Delta, using Adjusted SS for Tests 
 
Source    DF     Seq SS     Adj SS     Adj MS     F      P 
Minute    24  0.0015801  0.0015801  0.0000658  1.64  0.032 
Session   11  0.0035372  0.0035372  0.0003216  8.03  0.000 
Error    264  0.0105716  0.0105716  0.0000400 
Total    299  0.0156889 
 
 
S = 0.00632802   R-Sq = 32.62%   R-Sq(adj) = 23.68% 
 
 
Analysis of Variance for Theta, using Adjusted SS for Tests 
 
Source    DF     Seq SS     Adj SS     Adj MS     F      P 
Minute    24  0.0009581  0.0009581  0.0000399  0.98  0.493 
Session   11  0.0031191  0.0031191  0.0002836  6.96  0.000 
Error    264  0.0107493  0.0107493  0.0000407 
Total    299  0.0148265 
 
 
S = 0.00638100   R-Sq = 27.50%   R-Sq(adj) = 17.89% 
 
 
 
Analysis of Variance for Alpha, using Adjusted SS for Tests 
 
Source    DF     Seq SS     Adj SS     Adj MS     F      P 
Minute    24  0.0016410  0.0016410  0.0000684  0.71  0.841 
Session   11  0.0082065  0.0082065  0.0007460  7.74  0.000 
Error    264  0.0254517  0.0254517  0.0000964 
Total    299  0.0352992 
 
 
S = 0.00981875   R-Sq = 27.90%   R-Sq(adj) = 18.34% 
 
 
Analysis of Variance for LowBeta, using Adjusted SS for Tests 
 
Source    DF     Seq SS     Adj SS     Adj MS     F      P 
Minute    24  0.0007441  0.0007441  0.0000310  0.88  0.633 
Session   11  0.0026605  0.0026605  0.0002419  6.85  0.000 
Error    264  0.0093272  0.0093272  0.0000353 
Total    299  0.0127319 
 
 
S = 0.00594395   R-Sq = 26.74%   R-Sq(adj) = 17.03% 
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Analysis of Variance for HighBeta, using Adjusted SS for Tests 
 
Source    DF     Seq SS     Adj SS     Adj MS     F      P 
Minute    24  0.0079419  0.0079419  0.0003309  1.58  0.045 
Session   11  0.0130759  0.0130759  0.0011887  5.67  0.000 
Error    264  0.0553263  0.0553263  0.0002096 
Total    299  0.0763442 
 
 
S = 0.0144765   R-Sq = 27.53%   R-Sq(adj) = 17.92% 
 
 
 
Analysis of Variance for Gamma, using Adjusted SS for Tests 
 
Source    DF     Seq SS     Adj SS     Adj MS     F      P 
Minute    24  0.0083055  0.0083055  0.0003461  1.66  0.029 
Session   11  0.0136444  0.0136444  0.0012404  5.97  0.000 
Error    264  0.0548972  0.0548972  0.0002079 
Total    299  0.0768471 
 
 
S = 0.0144203   R-Sq = 28.56%   R-Sq(adj) = 19.09% 
 
 
 
Analysis of Variance for T/LB, using Adjusted SS for Tests 
 
Source    DF    Seq SS   Adj SS  Adj MS     F      P 
Minute    24   18.7700  18.7700  0.7821  2.12  0.002 
Session   11   36.5648  36.5648  3.3241  9.02  0.000 
Error    264   97.2409  97.2409  0.3683 
Total    299  152.5757 
 
 
S = 0.606908   R-Sq = 36.27%   R-Sq(adj) = 27.82% 
 
 
 
Analysis of Variance for T/HB, using Adjusted SS for Tests 
 
Source    DF    Seq SS   Adj SS  Adj MS     F      P 
Minute    24   36.3625  36.3625  1.5151  6.11  0.000 
Session   11   20.8368  20.8368  1.8943  7.64  0.000 
Error    264   65.4268  65.4268  0.2478 
Total    299  122.6260 
 
 
S = 0.497824   R-Sq = 46.65%   R-Sq(adj) = 39.57% 
 
 
 
Analysis of Variance for T/B, using Adjusted SS for Tests 
 
Source    DF    Seq SS    Adj SS   Adj MS     F      P 
Minute    24   8.10683   8.10683  0.33778  4.82  0.000 
Session   11   5.77449   5.77449  0.52495  7.49  0.000 
Error    264  18.50584  18.50584  0.07010 
Total    299  32.38715 
 
 
S = 0.264760   R-Sq = 42.86%   R-Sq(adj) = 35.29% 
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Analysis of Variance for T/A, using Adjusted SS for Tests 
 
Source    DF    Seq SS    Adj SS   Adj MS      F      P 
Minute    24   1.98883   1.98883  0.08287   2.05  0.003 
Session   11   8.78168   8.78168  0.79833  19.74  0.000 
Error    264  10.67722  10.67722  0.04044 
Total    299  21.44773 
 
 
S = 0.201107   R-Sq = 50.22%   R-Sq(adj) = 43.62% 
 
 
 
Analysis of Variance for Focus, using Adjusted SS for Tests 
 
Source    DF   Seq SS   Adj SS  Adj MS      F      P 
Minute    24   83.614   83.614   3.484   4.35  0.000 
Session   11  285.243  285.243  25.931  32.39  0.000 
Error    264  211.370  211.370   0.801 
Total    299  580.227 
 
 
S = 0.894787   R-Sq = 63.57%   R-Sq(adj) = 58.74% 
 
 
 
Analysis of Variance for Alertness, using Adjusted SS for Tests 
 
Source    DF   Seq SS   Adj SS  Adj MS      F      P 
Minute    24   92.161   92.161   3.840   3.51  0.000 
Session   11  141.027  141.027  12.821  11.72  0.000 
Error    264  288.891  288.891   1.094 
Total    299  522.079 
 
 
S = 1.04608   R-Sq = 44.67%   R-Sq(adj) = 37.33% 
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 Pearson Correlation Output 
 
        Focus     T/A     T/B    T/LB    T/HB       A      LB      HB 
T/A    -0.676 
        0.000 
 
T/B    -0.612   0.600 
        0.000   0.000 
 
T/LB   -0.633   0.828   0.896 
        0.000   0.000   0.000 
 
T/HB   -0.577   0.523   0.993   0.843 
        0.000   0.001   0.000   0.000 
 
A       0.444  -0.733  -0.316  -0.526  -0.248 
        0.006   0.000   0.057   0.001   0.138 
 
LB      0.423  -0.710  -0.513  -0.670  -0.463   0.846 
        0.009   0.000   0.001   0.000   0.004   0.000 
 
HB      0.373  -0.463  -0.579  -0.541  -0.573   0.465   0.795 
        0.023   0.004   0.000   0.001   0.000   0.004   0.000 
 
Theta  -0.197  -0.045   0.328   0.138   0.369   0.584   0.356   0.010 
        0.242   0.793   0.047   0.417   0.024   0.000   0.031   0.953 
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